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3Father and Daughter: A Father’s Privilege
Child, why would you want to practice medicine?
Late hours, night calls, research projects, administration deadlines
Don’t do medicine, look at my life
Do what makes you happy
Daughter, why are you stressing?
Don’t do this. There are easier ways to make a living
It’s not worth it, go ahead and live
Do what makes you happy
Doctor, don’t you know there is a price for learning?
Nothing worth doing is done easily
The struggle cries there must be an easier way
Do what makes you happy
Dear Heart, you have chosen a difficult road and kept true
In medicine we meet as equals
An old man with eyes that leak now and again
Glad and proud that you do what makes you happy
Spencer S. Kee
This thesis is dedicated to the memory of my father
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Chapter 1
General introduction
Adapted from: Moerman A, Wouters P. Near-infrared spec-
troscopy (NIRS) monitoring in contemporary anesthesia
and critical care. Acta Anaesth Belg 2010; 61: 185-94
The primary goal in the hemodynamic management of patients
undergoing surgery is to preserve oxygen delivery at a level sufficient
to cover all metabolic needs. Nowadays, anesthesiologists can rely on
a variety of monitoring tools to quantify cardiovascular performance
and global oxygen delivery. Nonetheless, current standard anesthesia
monitoring still has two major drawbacks. First, it provides a global
assessment of the patient’s status, and as such vital organ ischemia
may go unnoticed until functional organ damage becomes evident.
Case reports of dramatic neurologic outcome after minor surgery
in healthy patients [1] point out the compelling need for organ-
specific monitoring. A second drawback is that the majority of
variables monitored in contemporary anesthesia focus on oxygen
supply (cardiovascular performance, hemoglobin and arterial oxygen
content) but do not assess imbalances between oxygen supply and
demand. The use of central and mixed venous oxygen measurements
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to assess oxygen consumption is gaining interest now in perioperative
care [2]. However, current techniques for assessing venous oxygen
saturation are invasive and therefore not routinely incorporated into
clinical anesthesia.
Near-infrared spectroscopy (NIRS) is a non-invasive technology
that continuously monitors regional tissue oxygenation. NIRS was
originally introduced in clinical practice in 1985, for the assessment
of cerebral oxygenation in preterm infants [3]. It was also welcomed
with enthusiasm in cardiac and neuro-anesthesia, but its utility,
particularly in the latter field of application, was seriously challenged
by a series of reports on false positive as well as false negative
readings. The technique was further discredited by anecdotal papers
illustrating that NIRS oximeters generated near normal values when
the probes were placed on an empty human skull filled with blood-
soaked gauzes [4] or even on a pumpkin [5]. Even today, these papers
are quoted to question the validity of NIRS monitoring. However,
a fair understanding of the assumptions and limitations of NIRS
technology suffice to understand that such observations are indeed
possible, yet do not invalidate the use of NIRS to quantify changes
in the oxygen status of human tissue. The interest in NIRS as a
monitoring tool in anesthesia has revived over the past few years and
several systems have now been approved for clinical use.
1.1 Near-infrared spectroscopy
The first attempt to monitor human tissue oxygenation non-invasively
dates back to 1874 when the German physiologist Karl Von Vierordt
showed that the amount of red light transmitted through a hand
decreased after it was made ischemic [6]. His pioneering studies were
essentially ignored for half a century until it was again reported
that the variable transmission of red and infrared light through a
human ear reflected changes in blood oxygenation [7]. The first
small portable oximeter was developed in 1942 by Glen Milliken
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[8], although the device was used only as an experimental tool in
the aviation and the physiology laboratory. The concept of cerebral
near-infrared spectroscopy originated with the observations of Jobsis
[9] who irradiated a cat’s head with near-infrared light and found
that the intensity of the transmitted light varied with the oxygen
metabolic state of the brain (Fig. 1.1).
Figure 1.1
1.1.1 Principles of operation
The physical and mathematical basis for NIRS is provided by the
Beer-Lambert law, which states that the quantity of light absorbed
by a substance (A) is directly proportional to the specific absorp-
tion coefficient of the substance at a particular wavelength (), the
concentration of the substance (c) and the pathlength of the light
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through the solution (l) (A =  · c · l) [10].
The relative transparency of biological tissues to light in the near-
infrared part of the spectrum (700-1000 nm) enables light photons
to pass through the tissues, where they are attenuated due to a
combination of absorption and scattering. Because of scattering
by the tissue components, the light does not travel in a straight
line. Therefore, the Modified Beer-Lambert law is applied: (A =
 · c · l ·B + k), where B is the differential pathlength factor and k is
an additive geometry-dependent term, reflecting scatter loss. The
geometrical pathlength l has to be multiplied by B to find the true
optical distance, because light that reaches the detector will have been
scattered multiple times and therefore has travelled a much greater
distance than the actual light emitter-detector distance. k corrects
for the fact that not all emitted light reaches the detector, because
some of it is scattered away from the detector, giving scattering losses.
Scattering is a function of the tissue composition and the number of
various tissue interfaces. Because B and k are unknown factors, no
absolute values can be measured with the Modified Beer-Lambert
law. NIRS technology is based on the assumption that the quantity
of scattering remains constant and that changes in attenuation result
solely from changes in absorption.
Several biological molecules, termed chromophores, absorb light
in the near-infrared (NIR) spectrum. However, only hemoglobin
and cytochrome oxidase are present in variable concentrations,
reflecting blood and intracellular oxygenation, respectively. Other
chromophores are assumed to be constant over the period of moni-
toring.
The wavelengths of NIR light used in commercial devices are
selected to be sensitive to hemoglobin. Cytochroom oxidase has a
crucial role in mitochondrial oxidative energy metabolism, and there-
fore provides a potential biomarker of the cellular oxygenation state,
with substantial physiological and clinical importance. However, it is
present in much lower concentrations in the tissue than oxygenated
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and deoxygenated hemoglobin and its absorption spectrum overlaps
that of these chromophores, and therefore, the validity of cytochroom
oxidase measurements is debated, and the signal is not incorporated
into any clinical monitors yet [11].
Oximetry relies on the fact that absorption of near-infrared
light at specific wavelengths is different in deoxygenated hemoglobin
(HHb) when compared with oxygenated hemoglobin (O2Hb) (Fig.
1.2).
Figure 1.2: Distinct absorption spectra for water (H2O),
lipids, oxygenated (O2Hb) and deoxygenated hemoglobin (HHb).
Near-infrared spectroscopy measures light absorption at spe-
cific wavelengths to differentiate between O2Hb and HHb.
(https://Dosi.bli.uci.edu/userfiles/image/basis spectra.jpg)
Commercial devices generally use wavelengths between 690 and
880 nm where the absorption spectra of O2Hb and HHb are max-
imally separated and there is minimal overlap with that of water
absorption (980 nm) (Fig. 1.2). Optical absorption at 1 wavelength
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for each chromophore of interest must be known. NIRS devices use
near-infrared light at two or more specific wavelengths to differentiate
between O2Hb and HHb. Similar to the principles used in pulse
oximetry, the device measures the amount of light absorbed at these
specific wavelengths and calculates the relative contribution of O2Hb
and HHb. The resulting ratio of O2Hb to total Hb (THb) (expressed
as a percentage) represents the oxygen saturation of tissue under the
sensor: O2Hb.k/THb.k.100(%), in which k, the constant reflecting
the scattering, can be neglected. No attempt is made to measure
optical scattering. The scale of measured changes is dependent on the
application of assumptions of the scattering properties at different
wavelengths, and is incorporated into the algorithm of the respective
devices. Algorithmic formulae are complex, and their validity is
contingent on the assumptions made. The variability in algorithms
between NIRS devices implicates that there are differences in the
chromofore concentrations derived, making comparisons between
oximeters produced by different manufacturers problematic.
Jobsis [9] used transmitted light in his original experiments. Light
was applied to one side of the body and received on the other
side. However, attenuation of light due to absorption and scat-
tering restricts usage of this method to very thin and transparent
areas of the body such as the earlobe or finger. For that reason,
reflected light rather than transmitted light is being used to study
absorption of light in larger tissue samples. Reflectance probes locate
the light emitter and detector adjacent to one another. The light
takes a “banana-shaped” pathway through the tissues, with the depth
of photon penetration proportional to the source-detector separation
(principle of spatial resolution) (Fig. 1.3). In order to compensate
for superficial tissue, which is not the tissue of interest, differentially
spaced light detectors are used. Owing to the principle of spatial
resolution, the closer receiver will measure more superficial tissue
while the distal optode measures both superficial and deeper tissue.
After subtraction of the interference from superficial tissues – the
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mathematical details of which are not provided by the manufacturers
– oxygenation in the deeper tissues is derived.
Figure 1.3: Principle of reflectance spectroscopy and spatial resolution
(Permission for reproduction obtained from Somanetics Corporation, Troy,
MI, USA).
1.1.2 Assumptions and limitations
As with any monitoring system it is essential for the clinician to
understand its underlying technology, including the limitations and
the assumptions made to translate a physical quantity into a clinically
meaningful parameter.
First of all, NIRS does not quantify oxygen molecules, but cal-
culates the ratio of light absorbencies at predefined wavelengths.
External light sources may cause significant artefacts and careful
shielding of the probes is therefore important. Theoretically any
substance to which NIRS is applied can generate a value on the
monitor. In fact, the technology is being used for more than 20 years
now in the agricultural, chemical, and pharmaceutical industries, e.g.
to determine the freshness of food.
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Second, the algorithms used to calculate oxygen saturation
assume a fixed distance for light to travel through the sampled
area (the optical pathlength). However, different tissue components
produce very different amounts of photon scattering and absorption.
As a result, variations in probe positioning [12] as well as interindi-
vidual variations in the composition of tissue may result in 10 to
15% variability of the true optical pathlength measurement [13]. In
fact, for cerebral NIRS, the influence of extracranial tissue and blood
on the optical pathlength is not known [14]. It is therefore impos-
sible to completely eliminate the potential interference of changes
in extracranial flow on cerebral NIRS readings [15]. The significant
inter-individual biological variability in tissue composition causes a
wide variation in ‘normal’ baseline values of volunteers. Therefore,
NIRS devices are best used as trend monitors. Rather than to base
therapeutic decisions on absolute numbers, it is safer to rely on
proportional changes of an individual’s baseline value as a basis for
clinical decision making. Although individual manufacturers claim
that some monitors provide reliable absolute values which can be
applied universally, this statement lacks any scientific basis. In fact,
to subscribe such a statement, validation studies would be required
to compare NIRS data to invasive measurements of oxygen saturation
in tissue samples obtained directly from the brain. Such studies have
not yet been performed.
Third, the physiological correlate to which tissue saturation mea-
surements obtained with NIRS relate, remains a matter of debate.
NIRS measurements are continuous, i.e. not time-gated with respect
to the cardiac cycle. Furthermore, the interrogated tissue sample
contains all the different vascular components and represents a mix-
ture of arterial, capillary and venous oxygen saturations. In contrast,
pulse oximetry incorporates the variation in optical density during
the cardiac cycle which enables it to define the systolic fraction of
the signal. It calculates the ratio between systolic and diastolic
absorption values to determine arterial oxygen saturation (SaO2). In
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contrast to NIRS, pulse oximeters have been subjected to a calibra-
tion procedure. During calibration, readings from pulse oximeters are
being compared to simultaneously obtained arterial blood samples
from volunteers who undergo a controlled desaturation (down to
values of 70% SaO2). For NIRS measurement, the precise contribu-
tion from the various vascular beds is not known, but is assumed to
represent a 30/70 ratio (or 20/80) of arterial to venous components
[16]. However, relative changes in blood volume of the venous or
arterial compartment can influence cerebral saturation independently,
without a true change in saturation of either. A simple example
of this is a change from the head-elevated Fowlers’ position to the
head-down Trendelenburg position [17].
Finally, one of the major criticisms against the use of NIRS as
a neuromonitor is that marked decreases in cerebral oximetry may
occur without apparent resultant neurological damage. It should be
clear that low cerebral saturations reflect an oxygenation imbalance,
indicating a potential risk of ischemia, but does not necessarily
indicate tissue damage. The transition to irreversible injury depends
on both the severity and duration of hypoxia. On the other hand, the
measurements obtained with NIRS are regional, and strictly confined
to the zone beneath the sensor. Clinically relevant focal cerebral
ischemia in a brain area remote from the monitored area may easily
go unnoticed. These limitations undoubtedly explain the relatively
low sensitivity and specificity reported for carotid endarterectomy
[18].
1.1.3 Validation
Several difficulties arise in the validation of cerebral oximetry, because
there is no invasive direct measurement possible of the true oxygen
saturation in the interrogated brain tissue. The accuracy of NIRS
has been validated by comparison to internal jugular vein oxygen
saturation (SjvO2) [19-22]. However, some factors need to be taken
into account when validating the accuracy of any cerebral oximeter
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with SjvO2: there is a considerable anatomical variation of cerebral
venous drainage [23], NIRS measures regional oxygen saturation,
whereas SjvO2 reflects global brain oxygenation, and SjvO2 measures
venous oxygen saturation, whereas NIRS represents a mixture of
arterial, capillary and venous oxygen saturation, of which the precise
contribution of each compartment is not known [16]. Because of their
fundamentally different sampling character, an expectation of close
agreement between these measures is unjustified.
1.2 Clinical considerations in cerebral NIRS
monitoring
Figure 1.4: Illustration of placement of NIRS sensors (Permission for
reproduction obtained from Somanetics Corporation, Troy, MI, USA).
To obtain an individual reference baseline value, NIRS monitoring
is best initiated before preoxygenation and anesthesia induction.
Self-adhesive sensors containing the infrared light source and light
detectors are fixed on one or both sides of the forehead (Fig. 1.4).
The values reported for regional cerebral oxygen saturation (rScO2)
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are 71 ± 6% in young healthy adults [20] compared with 67 ± 10%
in cardiac surgery patients [24].
In most clinical studies cerebral desaturation is defined as a 20%
reduction from baseline values or an absolute decrease below 50%
[24]. However, the risk of irreversible tissue damage increases with
the duration of cerebral desaturation. The degree and duration of
reduction in rScO2 associated with development of permanent neu-
rologic injury was defined in experimental and clinical studies. In a
piglet model, rScO2 reductions to 30-45% produced immediate neu-
rophysiologic impairment, manifested by increased lactate, decreased
brain adenosine triphosphate (ATP), and altered synaptic activity
[25], and by injury of mitochondria in the neurons [26]. If a rScO2
of 35% lasted more than 2 hours, the incidence of structural brain
damage increased linearly by about 15% per hour [27]. In neonates
with hypoplastic left heart syndrome, prolonged low postoperative
cerebral oximetry (<45% for >180 minutes) was associated with the
development of new or worsened ischemia on postoperative magnetic
resonance imaging [28]. Slater et al. identified a desaturation score of
3000 %.sec (calculated by the product of length of time and depth of
rScO2 <50%) to be an independent predictor of postoperative cogni-
tive decline and extended hospital length of stay [29]. It is important
to note that thresholds for the onset of cerebral impairment depend
on the ‘cerebral blood flow reserve’, which is patient and disease
specific, and which is also modified by factors, such as anesthesia,
vasoactive drugs, and tissue temperature [30]. Therefore, there may
be a much smaller margin for error with respect to cerebral ischemia
than anticipated.
Figure 1.5 illustrates NIRS monitoring during anesthesia for
defibrillator implantation. During anesthesia induction (Fig. 1.5(A))
an increase in rScO2 is seen due to preoxygenation and suppression
of cerebral metabolism. To test proper functioning of the defibrilla-
tor, ventricular fibrillation was induced, resulting in immediate and
profound cerebral desaturation (Fig. 1.5(B)). After restoration of
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circulation by defibrillation, rScO2 instantly normalized.
Figure 1.5: Time plot of cerebral oxygen saturation (rScO2) from the
left (blue line) and right (pink line) frontal cortex during implantation of a
defibrillator. A: Anesthesia induction. B: Ventricular fibrillation.
A clinical algorithm to correct for decreases of rScO2 values is
depicted in table 1.1 on page 22. In case of decrease, first step is
to rule out technical or mechanical causes. Verify that the sensors
are well positioned, because an inappropriately applied sensor will
capture ambient light and may display a wrong value [31]. Then
rule out technical and mechanical causes of hypoperfusion. During
extracorporeal circulation, a malpositioned arterial or venous cannula
may compromize cerebral perfusion pressure, resulting in immediate
cerebral desaturation. Proper repositioning of the cannula instanta-
neously leads to effective restoration of rScO2 (Fig. 1.6). Since the
introduction of NIRS in cardiac surgery, it turned out that NIRS
is often the first and only indicator of cannula malpositioning [32],
which strongly suggests that the incidence and impact of cannula
misplacement have been underestimated in the past.
Once technical and mechanical problems have been excluded,
the next step is to optimize those factors that influence NIRS
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Figure 1.6: Time plot of cerebral oxygen saturation (rScO2) from the
left (blue line) and right (pink line) frontal cortex. Malpositioning of the
venous cannula in the superior caval vein (VCS) induces immediate cerebral
desaturation (arrow).
values. A change in NIRS values can be caused by a wide variety
of pathophysiological conditions since every parameter that affects
oxygen balance, both supply and demand, will change tissue oxy-
gen saturation. Cerebral oxygen delivery can be increased by
optimizing cardiac output and increasing arterial oxygen content
(PaO2, hemoglobin (Hb)). Considering Hb is an important deter-
minant of tissue oxygenation, low rScO2 values may be related to
low Hb levels. Some investigators have proposed using rScO2 as
a transfusion trigger [33,34]. However, transfusion will not invari-
ably increase rScO2 [35], considering Hb is only one determinant
of tissue oxygenation and since blood processing may reduce Hb
oxygen-carrying capacity by up to 90% [36].
Because the cerebral circulation is very responsive to changes in
carbon dioxide (CO2), deliberate hypercapnia will increase rScO2.
In a patient with normal CO2 reactivity, cerebral blood flow changes
1-2 ml/100g/min per mmHg CO2 change [37].
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Table 1.1: Algorithm to correct cerebral oxygen desaturation
Step 1:
Check, check, check - Check oximeter/sensors
- Check equipment (ventilator/pump)
- Check head/cannula position
Step 2:
Optimize cerebral oxygen supply - If reduced or maldistributed cardiac
output: volume infusions, inotropics,
vasodilators, etc...
- If PaO2 too low : Raise FiO2/PaO2
- If Ht<25% : Blood transfusion
- If PaCO2<45 mmHg : Raise PaCO2
- Raise perfusion pressure
Step 3:
Decrease cerebral oxygen - Control hyperthermia
consumption - Increase anesthetic depth
- Neuroprotective agent
PaO2: arterial oxygen partial pressure, FiO2: fractional inspired oxygen, Ht:
hematocrit, PaCO2: arterial carbon dioxide partial pressure.
Theoretically, cerebral blood flow should be constant when cere-
bral perfusion pressures range between 50 and 150 mmHg. However,
this concept of cerebral autoregulation is increasingly questioned,
since there is an enormous individual variation in the autoregulation
limits [30], and multiple causes during surgery might impair cerebral
autoregulation such as hypothermia, vasoactive drugs, anesthetics,
endothelial dysfunction and inflammatory responses [38,39]. It was
shown that NIRS has the potential to identify impaired cerebral
autoregulation and to detect otherwise unnoticed cerebral hypoper-
fusion [40-42].
If a reduction in rScO2 values is observed despite optimization of
cerebral oxygen delivery, steps to decrease cerebral oxygen consump-
tion can be taken such as brain cooling and increasing anesthetic
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depth.
In summary, decreasing NIRS values undeniably reflect a deterio-
ration of the oxygen delivery-demand balance which should trigger
a search for potential causes and provide an early opportunity for
therapeutic correction.
1.3 Clinical studies
There is an exhaustive and still growing body of literature concerning
the use of NIRS in clinical anesthesia. Whereas initial research
focused on the use of NIRS as a mere brain monitor in neurosurgery
and cardiovascular surgery, now interest extends to other surgical
areas and to the evaluation of oxygenation of tissues other than the
brain.
Neurosurgery/neurointensive care/interventional neuroradiology
The reliability of NIRS in the setting of neurosurgery and neu-
rointensive care has been seriously questioned. In conditions where
the brain is threatened, light absorption and scattering is highly
variable, making accurate quantification impossible [43]. Also, NIRS
values vary greatly after a neurological insult, depending on the
secondary pathophysiological processes, defying interpretation [44].
Importantly, Maeda et al. [45] found cerebral oxygenation values
ranging from 0.3% to 95% in 214 human cadavers. The variation
was dependent on the total hemoglobin content, cause of death, and
cadaver-storage conditions. Obviously, these data indicate that NIRS
would not qualify to assess cerebral death.
NIRS monitoring may have a useful role in the detection and
management of adverse events during neuroradiologic endovascular
procedures. Bhatia et al. demonstrated that vasospasms as detected
from angiography were strongly associated with reductions in ipsi-
lateral NIRS values [46]. NIRS monitoring enabled prompt diagnosis
and management of adverse intraoperative events in a study of 28
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endovascular embolization procedures [47]. However, using NIRS in
this specific setting requires accurate interpretation of measurements,
with careful understanding of the ongoing step of the neuroradiologic
procedure, and considering the influence of extrinsic factors that
can affect results, such as patient systemic variables (blood pressure,
hemoglobin concentration, arterial oxygen concentration, arterial
carbon dioxide tension, cerebral metabolic rate). It is also impor-
tant to note that while decreases in rScO2 are sensitive indicators
of potentially threathening changes, the converse does not apply,
i.e. due to the regional measurement strictly confined to the zone
beneath the sensor, largely stable rScO2 values do not guarantee
cerebral integrity.
Cardiac surgery
As the incidence of neurologic complications is particularly high
in patients undergoing cardiac operations [48,49], the potential to
monitor the brain in a simple, non-invasive way was appealing for
anesthesiologists managing cardiac surgery patients.
In congenital heart surgery, most centres have adopted NIRS
very quickly as standard of care. Because changes in cerebral
hemodynamics and oxygenation are common during pediatric cardiac
surgery, putting these children at risk for brain damage, real-time
neurological monitoring is considered as an integral part of neuropro-
tective strategies for pediatric cardiac patients. A growing number of
case reports describe the early detection of potentially catastrophic
events by NIRS monitoring, which likely prevented brain injury
[50-52]. In addition, the potential for instantaneous hemodynamic
evaluation and timely intervention has been proven invaluable during
high risk pediatric cardiac surgery [53,54].
The interest in NIRS extended soon from congenital to adult
cardiac surgery. In several observational studies, routine use of periop-
erative cerebral oximetry monitoring in patients undergoing cardiac
surgery has been demonstrated to reduce neurological complications
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[55-57] and to shorten hospital stay [58]. However, to justify new
technology it is important to prove that interventions based on this
technology effectively improve clinical outcome. Currently, three
interventional trials in the domain of cardiac surgery and anesthesia
have addressed this question. The first one, from Goldman et al., com-
pared 1245 patients who underwent cardiac surgery before cerebral
oximetry was incorporated, with 1034 patients in whom rScO2 was
maintained near to each patient’s pre-induction baseline [59]. The
latter group had fewer permanent strokes (0.97% vs 2.5%), shorter
ventilation times, and decreased hospital stay. The weakness of this
study is its non-randomized and retrospective design. In the second
interventional trial, Murkin examined perioperative major organ mor-
bidity in a prospective, randomized, blinded study of 200 coronary
artery bypass patients [60]. Hundred patients were randomized to
intraoperative cerebral saturation monitoring with an active display
and treatment intervention protocol, and 100 patients underwent
blinded cerebral saturation monitoring. Significantly more major
organ dysfunction (death, ventilation >48 h, stroke, myocardial in-
farction) was observed in the control group versus the intervention
group. In the most recent interventional trial, Slater et al. found
that patients with a higher desaturation score (a score accounting for
both depth and duration of desaturation) had a significantly higher
risk of early postoperative cognitive decline and prolonged hospital
stay [29]. Due to poor compliance to the treatment protocol, Slater
was not able to demonstrate that treatment of cerebral desaturation
resulted in better outcome.
Carotid endarterectomy (CEA)
Perioperative stroke is a major risk of CEA. Stroke may be caused
by hypoperfusion during cross-clamping of the internal carotid artery
if collateral blood supply is insufficient, or by embolism during
insertion of a shunt. Many studies investigated the usefulness of
NIRS to detect patients developing cerebral ischemia during cross-
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clamping, trying to define the indication for a shunt. Although several
studies showed that rScO2 during carotid cross-clamping decreased
significantly more in patients who developed neurological symptoms
[18,61], defining a meaningful cutoff for decline in rScO2 associated
with neurologic threat is very difficult [62]. A 20% reduction in rScO2
from baseline is widely used as the threshold for shunt placement.
With this cutoff value, sensitivity between 30% and 83% was reported,
and specificity ranged between 25% and 98%, with a high negative
predictive value (98%), but an unacceptable low positive predictive
value (37%), hence cerebral oximetry cannot be relied on for decision
making about placement of a shunt during CEA [61,63,64]. Despite
the uncertainty as to the exact NIRS-derived threshold for the iden-
tification of critical ischemia, the body of evidence suggests broad
equivalence with other modalities for identifying critical cerebral
ischemia [61]. Although cerebral oximetry cannot be relied on for
decision making about placement of a shunt during CEA, NIRS
is currently used in many centres as the primary cerebral monitor
during carotid surgery to guide systemic physiological management
in order to optimize cerebral perfusion and oxygenation.
Noncardiac surgery
A large multicenter study (International Study of Post-Operative
Cognitive Dysfunction (ISPOCD) [65] showed that after major non-
cardiac surgery, postoperative cognitive dysfunction was present in
26% and 10% of the patients respectively at 1 week and 3 months
after surgery. Although the etiology is not completely clear, it is
assumed that unrecognized cerebral hypoperfusion can be impli-
cated in a significant number of perioperative brain damage. Casati
prospectively monitored rScO2 in 122 elderly patients undergoing
major abdominal surgery [66]. Twenty % of the patients experienced
a decrease in rScO2 below 75% of baseline. Correcting low rScO2
was associated with a lower incidence of immediate postoperative
confusion and an earlier hospital discharge.
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Other organ applications
The interest for using NIRS as a monitor of oxygen status in
tissues other than the brain is growing. Regional saturation monitor-
ing at somatic sites has been advocated as an early warning system
for changes in the oxygen supply-demand balance. As cardiac output
falls, the sympathetic stress response raises vascular resistance, re-
distributing blood flow to the brain and heart, leaving other tissues
– typically kidneys, liver, and intestines - at increased risk for silent
ischemia. Currently, rSO2 monitoring of kidneys [67-71], liver tissue
[72,73], splanchnic tissue [68,74] and muscles [68,75,76] are extensively
being studied to evaluate their potential to detect perfusion deficits.
Other promising applications of NIRS are prediction of splanchnic
ischemia in neonates [77,78], diagnosis of compartment syndrome [79],
assessment of peripheral vascular disease [80], monitoring of free flaps
[81,82], and monitoring of spinal ischemia during thoracoabdominal
aneurysm repair [83].
For all these applications it is important to realize that the mean
depth of light penetration is proportional to the light source-detector
distance, however the exact depth of penetration of near-infrared
light is not known [84]. For a number of applications there is little
evidence yet to guarantee that the device truly interrogates the
organ of interest. One of the concerns with these new applications
is that changes in the oxygen status of non-vital organs may be a
too sensitive marker for hemodynamic compromise and result in a
large number of unnecessary interventions. Future work is needed to
identify which of these applications are of benefit in clinical practice.
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1.4 Commercially available NIRS devices
Figure 1.7: Commercially available NIRS devices measuring cerebral
oxygen saturation.
Several NIRS devices for measuring cerebral oxygen saturation
are commercially available (Fig. 1.7), three of which are FDA-
approved: INVOS 5100 (Somanetics Corporation, Troy, MI, USA),
Foresight (CAS Medical Systems, Branford, CT, USA) and Equanox
7600 (Nonin Medical Inc., Minneapolis, MN, USA). NIRO-200NX
(Hamamatsu Phototonics Corp, Tokyo, Japan) is not FDA approved.
Despite the identical basic technology using near-infrared wavelengths
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to detect changes in the concentration of O2Hb and HHb, there are
several technical differences, which are summarized in table 1.2.
NIRO employs the technique of Spatially Resolved Spectroscopy
(SRS, multiple closely spaced detectors to measure light attenuation
as a function of source-detector separation) to measure tissue oxygen
saturation and change in hemoglobin. Independently of the SRS
method, NIRO measures changes in concentration of O2Hb, HHb
and THb using the Modified Beer-Lambert method. INVOS, Fore-
sight and Equanox use the Modified Beer-Lambert law to measure
tissue oxygen saturation, and eliminate the contribution of extra-
cerebral tissue by using the principle of Spatial Resolution (depth of
photon penetration proportional to the source-detector separation).
The NIRS devices also differ significantly in applied computational
algorithms to derive oxygen saturation values. Metz et al. evaluated
the effect of basic assumptions in the algorithm on the generated
NIRS values, and demonstrated that slight differences in the assump-
tions made, and the tissue investigated, have a relevant influence on
the final NIRS value [85]. Penetration depth could differ depending
on the wavelength and intensity of the emitted light, the sensitivity
of the light detector, and the spacing between the light emitter and
light detectors. The different devices also have a variable sensitivity
to extracranial tissue contamination [15]. Therefore the comparabil-
ity between the different NIRS devices is not clear. Since no real
reference value exists for rScO2, it is not possible to state if one
monitor is more valid than another.
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Table 1.2: Technical specifications of NIRS devices
NIRO INVOS Foresight Equanox
200NX 5100 7600
Measurement TOI (%)
items nTHI
∆O2Hb rSO2 (%) SctO2 (%) rSO2 (%)
∆HHb
∆THb
Measurement MBL MBL MBL MBL
methods SRS SR SR* SR
Light source LED LED Laser LED
Wavelengths 735,810, 730,810 690,778, 730,760,
(nm) 850 800,850 810,880
Detectors spacing n.a. 3 and 4 cm 1.5 and 5 cm 2 and 4 cm
Sensors Reusable Single use Single use Single use
TOI: Tissue Oxygenation Index, nTHI: normalized Tissue Hemoglobin Index
(arbitrary unit), ∆O2Hb: change in oxygenated hemoglobin (µmol/l), ∆HHb:
change in deoxygenated hemoglobin (µmol/l), ∆THb: change in total
hemoglobin (µmol/l), rSO2: regional oxygen saturation, SctO2: cerebral tissue
oxygen saturation, MBL: Modified Beer-Lambert law, SRS: Spatially Resolved
Spectroscopy, SR: Spatial Resolution, LED: Light-emitting diode, n.a.: not
applicable, *applied in the adult sensors only.
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Chapter 2
Objectives of the research
The present work aims to address the applicability of NIRS for the
detection of perioperative compromized tissue perfusion, and explores
its potential to assess the physiological determinants of tissue oxygen
saturation in different patients groups. The ultimate goal is the
optimization of patient care in daily anesthesia practice.
Chapter 1 briefly reviews the basic principles of operation, the
inherent limitations of the technology and the clinical data that have
been acquired with NIRS monitoring in the broad field of acute
clinical medicine.
Chapter 2 describes the objectives of the research project.
Chapter 3 discusses the use of NIRS monitoring for detection of
global cerebral perfusion deficit in patients at high risk for cerebrovas-
cular incidents, and also in patients at low risk for cerebrovascular
incidents, but undergoing surgery with a relatively high risk for
adverse neurological outcome. Physiological changes that were asso-
ciated with cerebral oxygen desaturation were identified.
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Chapter 4 reports the applicability of NIRS to monitor regional
organ perfusion. The use of NIRS is examined during aortic cross-
clamping, where the perfusion of the left brain, the peripheral tissues,
and the spinal cord has been temporarily interrupted. Determinants
of oxygenation debt are described.
Chapter 5 evaluates the feasibility of NIRS to provide a non-
invasive estimate of systemic venous oxygen saturation.
Chapter 6 explores the impact of different physiological
determinants of tissue oxygen saturation on cerebral and whole body
oxygen saturation.
Chapter 7 discusses the main findings and conclusions reported
in this thesis.
Chapter 8 summarizes future perspectives and proposals for
further research.
Chapter 3
NIRS for monitoring
global cerebral perfusion
3.1 Background
Despite its vital importance, the human brain remains a poorly
monitored organ in clinical anesthesia. Several clinical conditions
routinely encountered in our daily practice have the potential to
disrupt the balance between the cerebral oxygen supply and demand,
exposing to the risk of adverse postoperative neurological outcome.
These alterations in oxygen balance might remain unnoticed if we
do not specifically monitor it.
Central nervous system monitoring is technically difficult and
demanding, and therefore its use is not commonly incorporated into
routine anesthesia monitoring. Direct monitoring of brain oxygena-
tion can be obtained by direct measurement of brain tissue oxygen
tension (PtO2), or by monitoring the jugular venous oxygen satu-
ration (SjvO2). Limitations of these techniques are that PtO2 is a
focal measurement and therefore identification of ischemia is crucially
dependent on the position of the probe, whereas SjvO2 is a global
measurement which may miss regional ischemia. Furthermore, these
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techniques are invasive, may be associated with severe complications,
and are not usually available outside specialist centres. Transcranial
doppler ultrasonography (TCD) allows a non-invasive assessment of
the adequacy of cerebral blood flow by measuring blood flow velocity
in the proximal portions of large intracranial arteries. However, its
use is technically demanding and operator dependent, and unless
the diameter of the vessel is established by some other means it is
not possible to determine the actual blood flow. Electrical activity
in the brain can be measured non-invasively with electroencephalo-
graphy (EEG), allowing detection of brain ischemia. However, EEG
is difficult to interpret by non-specialists. Moreover, neither TCD
nor EEG provide direct information on the adequacy of brain tissue
oxygenation.
There is therefore the need for a non-invasive, easy to use, bed-
side monitor that provides a reliable and real-time assessment of
alterations in the cerebral oxygen balance. NIRS provides a non-
invasive, continuous method to measure cerebral oxygen saturation.
This technique has been demonstrated repeatedly to provide an early
warning sign of cerebral hypoperfusion during procedures with high
risk for adverse neurological outcomes.
3.2 Objective
The aim of the present studies was to evaluate NIRS monitoring in
patients where global cerebral perfusion might be compromized and
to identify the physiological changes that were associated with cere-
bral oxygen desaturation. Our study population comprised patients
undergoing shoulder surgery in the beach chair position, because
cases of dramatic neurological outcome in relatively healthy patients
undergoing this surgery, questioned the adequacy of brain perfusion
during beach chair position. We also evaluated NIRS monitoring in a
patient with moyamoya disease, in whom this underlying pathology
severely compromizes blood supply to the brain.
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3.3 NIRS monitoring in beach chair position
Cerebral oxygen desaturation during shoulder surgery in
beach chair position. A. Moerman, S. De Hert, T. Jacobs,
L. De Wilde, P. Wouters. Eur J Anaesthesiol 2012; 29: 82-
87
Abstract
Context. Cases of ischemic brain damage have been reported in
relatively healthy patients undergoing shoulder surgery in the beach
chair position. Unrecognized cerebral hypoperfusion may have
contributed to these catastrophic events, indicating that routine anes-
thesia monitoring may not suffice. Near-infrared spectroscopy (NIRS)
provides a non-invasive, continuous method to measure regional
cerebral oxygen saturation (rScO2).
Objectives. The aim of this clinical investigation was to evaluate
the prevalence of regional cerebral oxygen desaturation in patients
undergoing shoulder surgery in the upright position during routine
anesthesia management. We also aimed to identify some causal
factors for cerebral desaturation.
Design. Prospective, observational, blinded study.
Setting. University hospital. Observation period from 19 05 2008 to
26 08 2008.
Patients. Twenty consecutive adult patients presenting for elective
shoulder surgery under general anesthesia in the beach chair position
were enrolled. Patients with clinically apparent neurological or
cognitive dysfunction were excluded.
Interventions. Routine anesthesia management and standard moni-
toring were used. The responsible anesthesiologist was blinded to the
rScO2 data and was not informed about the purpose of the study.
Main outcome measures. The prevalence of cerebral oxygen desatu-
ration was measured.
Results. With beach chair positioning, rScO2 decreased significantly
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from 79 ± 9 to 57 ± 9% on the left side and from 77 ± 10 to 59 ± 10%
on the right side (P<0.001). A relative decrease in rScO2 of more
than 20% occurred in 80% of patients when the beach chair position
was adopted. Postural decreases in cerebral oxygenation were related
to blood pressure (r=0.60, P=0.007) and end-tidal carbon dioxide
concentration (r=0.47, P=0.035).
Conclusion. The high prevalence of significant cerebral oxygen
desaturation during shoulder surgery in the upright position un-
derlines the need for close monitoring. NIRS might constitute a
valuable technique to detect cerebral hypoperfusion in this high-risk
group of patients.
3.3.1 Introduction
A series of case reports reporting dramatic adverse neurological
outcomes in patients after shoulder surgery in the upright position
have recently alarmed the surgical and anesthesic communities. The
complications ranged from cranial nerve injury [1] to visual loss [2] and
cerebral infarction [3,4], occurring in relatively healthy middle-aged
patients considered to be at low risk for cerebrovascular incidents.
Although the exact pathogenesis of these events remains largely
unexplained, it has been assumed that the specific positioning of the
patient for shoulder surgery, that is, the beach chair position, may
be responsible for these complications. The beach chair position may
be associated with malrotation of the head and result in mechanical
obstruction of the cerebral vessels. It has also been suggested that
such positioning may induce unfavourable hemodynamic alterations
with cerebral tissue hypoperfusion related to the gravitational effect
of upright tilting. Finally, management of shoulder surgery often
includes general anesthesia with controlled hypotension, which may
further compromize cerebral blood flow. These reports mandate that
more attention should be paid to the effects of patient positioning on
cerebral perfusion and that in these circumstances, routine anesthesia
monitoring may not suffice.
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Near-infrared spectroscopy (NIRS) provides a non-invasive, con-
tinuous method of measuring cerebral tissue oxygen saturation. This
technique has been demonstrated repeatedly to provide an early
warning sign of cerebral hypoperfusion during procedures with a
high risk of adverse neurological outcomes [5]. Recent reports have
suggested that cerebral oximetry monitoring with NIRS may be a
useful indicator of cerebral hypoperfusion during shoulder surgery in
the beach chair position [6,7].
The aim of this prospective, observational, blinded study was
to evaluate the prevalence of regional cerebral oxygen desaturation
in patients undergoing shoulder surgery in the beach chair position
when routine anesthesia management and standard monitoring are
used. We also aimed to identify potential physiological changes that
might be associated with postural cerebral oxygen desaturation.
3.3.2 Methods
Ethical approval for this observational study (Ethical Committee
N◦ 2008/191) was provided by the Ethical Committee of the Ghent
University Hospital, Gent, Belgium (Chairperson Prof Dr R. Rubens)
on 30 April 2008. After written informed consent, 20 consecutive
unpremedicated adult patients scheduled for elective shoulder surgery
in the beach chair position were included. Exclusion criteria were
clinically apparent neurological or cognitive dysfunction.
Standard monitoring was used throughout the procedure, includ-
ing ECG, pulse oximetry (SpO2), end-tidal oxygen, carbon dioxide
and sevoflurane concentrations and non-invasive blood pressure mea-
surement (AS3; Datex, Helsinki, Finland). Blood pressure measure-
ments were performed at 3-min intervals with a non-invasive cuff
placed on the arm opposite the operated side. Disposable NIRS
sensors were applied on each side of the forehead for continuous
registration of the regional cerebral oxygen saturation (rScO2) of the
corresponding brain hemisphere (INVOS 5100; Somanetics Corpora-
tion, Troy, MI, USA).
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Anesthesia was induced with sufentanil (0.1-0.3 µg/kg), propo-
fol (2-3 mg/kg) and cisatracurium (0.1 mg/kg). Anesthesia was
maintained with sevoflurane (1.5-2.5% end-tidal concentration) in
an oxygen/air mixture (50% oxygen) and additional doses of sufen-
tanil (0.1-0.2 µg/kg), if needed. All patients were raised to a 60-
to 70-degree sitting position. The head of the patient was fixed in
the mid-line. Management of anesthesia and hemodynamics were
left completely to the discretion of the attending anesthesiologist,
who was blinded to the rScO2 data, and who also was not informed
about the purpose of the study. Routine clinical practice was used
to maintain blood pressure. No deliberate hypotension was used.
Systolic arterial pressure (SAP) of <80 mmHg or heart rate of <50
beats/min were usually treated.
Heart rate, non-invasive blood pressure, in- and end-expiratory
gas tensions, SpO2 and bilateral rScO2 were recorded continuously
with RUGLOOP (Demed, Temse, Belgium). Blood loss was estimated
and types and volumes of all fluids administered were recorded, as
well as doses of all drugs given. At the postoperative visit by the
responsible anesthesiologist on the evening of surgery, the patient was
assessed neurologically with a gross motor and sensory neurological
evaluation and a gross cognitive evaluation (orientation in time and
space, recall of name, date of birth, and address). Any side-effects
were recorded.
The rScO2 values were compared at different time moments
(awake, last value before position change from supine to upright posi-
tion, 5 min after position change to beach chair, and at the minimum
rScO2). Changes in cerebral oxygen saturation were described in
absolute terms (absolute rScO2 <50%) and in relative terms (>20%
decrease in rScO2 compared to the value before position change). A
rScO2 desaturation score was calculated by multiplying rScO2 below
50% with the duration of this event (in seconds) [8]. Hence, the rScO2
desaturation score generated is an area under the curve measurement,
which accounts for both severity and duration of desaturation.
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Sample size calculation was based on the assumption that a
relative decrease in saturation of 20% (the smallest effect to be
clinically important [9]) would be detected. Based on the study of
Kim et al. [10], a mean and standard deviation (SD) of 71% and
6% respectively were chosen. For a power of 0.8 and an α of 0.05, a
sample size of 20 patients was calculated to be appropriate to detect
a clinically relevant decrease in cerebral oxygen saturation. Statis-
tical analysis was performed using the statistical software PASW
Statistics 18 (SPSS Inc., Chicago, IL, USA). Data were tested for nor-
mal distribution using the Shapiro-Wilk test. Normally distributed
continuous data are presented as mean ± SD.
The rScO2 values at different time points were compared using an
analysis of variance for repeated measurements (ANOVA). Post-test
pairwise comparison was performed with the Tukey test. Possible re-
lationships between rScO2 and physiological variables were analyzed
using linear regression analysis and quantified using the Spearman’s
correlation tests. A value of P<0.05 was considered statistically
significant.
3.3.3 Results
Patient demographics are presented in Table 3.1. One patient had
undergone a carotid endarterectomy 4 years earlier, and another
patient suffered from a transient ischemic attack (TIA) 8 years
earlier; neither patient had any residual symptoms.
Table 3.2 shows details of surgery and anesthesia. All patients
received cristalloid solutions. If more than 1000 ml of cristalloids
were needed, colloids were administered (four patients). The surgical
procedures did not necessitate the use of deliberate hypotension and,
therefore, routine clinical practice was used. Seven patients received
ephedrine (5-10 mg) and one patient required phenylephrine 100 µg
to correct a SAP of <80 mmHg. Three patients needed atropine 0.5
mg for bradycardia (heart rate <50 beats/min).
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Table 3.1: Patient demographics
Sex, male/female (n) 5/15
Age, y 60.2 ± 13.4
Weight, kg 68.6 ± 17.6
Body mass index, kg/m2 25.2 ± 4.8
Medical history, n Hypertension: 11
Neurological history: 2
Cardiovascular medication: 11
Data are expressed as mean ± SD
Table 3.2: Details about surgery and anesthesia
Duration beach chair, min 78 ± 45 [20 - 151]
Blood loss, ml 186 ± 277 [5 - 1000]
Fluids before beach chair, ml 187 ± 186 [50 - 650]
Fluids during beach chair, ml 625 ± 444 [150 - 2100]
Sufentanil dose, µg/kg 0.24 ± 0.07 [0.1 - 0.38]
Drug use, n Ephedrine: 7
Atropine: 3
Phenylephrine: 1
Urapidil: 1
Data are expressed as mean ± SD [range]
The postural changes in cerebral oxygen saturation and blood
pressure are shown in Table 3.3. When the beach chair position
was adopted, rScO2 decreased significantly from 79 ± 9% to 57 ±
9% on the left side and from 77 ± 10% to 59 ± 10% on the right
side (P<0.001 for both sides compared with baseline, no significant
difference between sides). A relative decrease in rScO2 of >20%
occurred in 80% of patients when the beach chair position was
adopted. In 30% of patients, rScO2 decreased to an absolute value
below 50%. Desaturation scores ranged from 0 to 725%.sec (mean ±
SD: 89 ± 221%.sec) on the left side and from 0 to 3360%.sec (178 ±
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Table 3.3: Postural changes in cerebral oxygen saturation and in blood
pressure
LeftrScO2 RightrScO2 SAP/DAP
(%) (%) (mmHg)
Awake 69 ± 6 68 ± 6 156 ± 29/76 ± 20
Before position change 79 ± 9 77 ± 10 130 ± 32*/67 ± 20
5 min position change 65 ± 10‡ 66 ± 11‡ 110 ± 24*‡/64 ± 24
Minimum value 57 ± 9*‡ 59 ± 10*‡ 84 ± 22*‡/46 ± 11*‡
Data are expressed as mean ± SD. rScO2: regional cerebral oxygen saturation.
*p<0.05 vs awake value. ‡ p<0.05 vs value before position change.
750%.sec) on the right side. One patient had a desaturation score of
more than 3000%.sec.
The patient who had undergone carotid endarterectomy had a
maximum relative decrease in rScO2 of 12.7% (minimum rScO2 55%).
The patient with a history of TIA had a relative decrease of 30.4%
(minimum rScO2 64%).
At all time points, rScO2 was negatively correlated with age (Fig.
3.1 (upper panel)), but the magnitude of the decrease in rScO2 with
position change was independent of age (Fig. 3.1 (lower panel)).
Before the position change, there was a positive correlation be-
tween rScO2 and end-tidal carbon dioxide (EtCO2) (r = 0.53, P =
0.016). No correlation was found between rScO2 and SAP (r = 0.28,
P = 0.086). Five minutes after the change in position, a positive
correlation was found between rScO2 and EtCO2 (r = 0.56, P =
0.013), but no correlation was found between rScO2 and SAP (r
= 0.29, P = 0.076). At the minimum rScO2, there were positive
correlations between rScO2 and EtCO2 (r = 0.47, P = 0.035) and
between rScO2 and SAP (r = 0.60, P = 0.007).
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Figure 3.1: Upper panel: Correlation of age with regional cerebral oxy-
gen saturation (rScO2) before position change (crosslets) (y=-0.4x+103;
r=-0.59; P<0.001), 5 minutes after position change (open circles)
(y =-0.4x+92; r=-0.54; P<0.001), and minimum rScO2 (closed circles)
(y=-0.3x+76; r=-0.41; P=0.033). Lower panel: Correlation of age with
magnitude of rScO2 decrease after change to beach chair position.
A representative case is shown in Fig. 3.2. The rScO2 decreased
promptly when the position was changed from supine to the beach
chair position and immediately recovered when the supine position
was restored. Changes in rScO2 closely paralleled changes in blood
pressure, which is also apparent from the effects of ephedrine.
None of the patients developed gross neurological or cognitive
dysfunction postoperatively.
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Figure 3.2: Representative case. Changes in regional cerebral oxygen
saturation (rScO2) at the start (1) and the end (4) of the beach chair
position and after administration of atropine (2) and ephedrine (3).
3.3.4 Discussion
In the present study, we observed cerebral desaturation (a relative
decrease in rScO2 of >20%) in 80% of patients when an upright
position was adopted during shoulder surgery. Postural decreases in
cerebral oxygenation were consistent and related to blood pressure
and EtCO2.
Recently, three reports have described the value of NIRS in
monitoring the adequacy of cerebral perfusion during shoulder surgery
in the beach chair position. Fischer et al [6] reported a case showing
causality between rScO2, mean arterial pressure (MAP) and EtCO2.
Murphy et al. [7] evaluated the incidence of cerebral desaturation
during shoulder surgery in the beach chair position compared to
the lateral decubitus position. They used standardized anesthetic
management and aimed to optimize cerebral perfusion by maintaining
MAP within 20% of baseline values and controlling EtCO2 between
30 and 34 mmHg. When cerebral oxygen desaturation was observed,
they used a predetermined management protocol to increase rScO2.
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In the study of Tange et al. [11], perioperative management included
support stockings, fluid administration at a rate of 10 ml/kg/h
throughout the study period, gradual head-up tilt position, and
careful blood pressure management to maintain MAP above 60
mmHg. All these measures aimed to minimize the impact of position
change. Our study is different in that the objective was to evaluate
the actual prevalence of regional cerebral oxygen desaturation in
patients undergoing surgery in the beach chair position when standard
anesthesia management and routine anesthesia monitoring (which
currently does not include cerebral oximetry) were employed. For
this reason, anesthetic management was left to the discretion of the
attending clinicians who did not participate in the study and were
blinded to the rScO2 data.
It is assumed that the upright position induces significant hemo-
dynamic changes that may impair cerebral circulation. Compared
to the supine position, adopting an upright position has been shown
to decrease systolic and mean arterial pressure, stroke volume and
cardiac output, inducing a cerebral blood flow decrease of 12% [12].
In conscious individuals, these effects are compensated for by an
increase in systemic vascular resistance, but during anesthesia this
autonomic response may be attenuated or blocked. The combina-
tion of the sitting position and general anesthesia may, therefore,
be potentially deleterious to cerebral perfusion. Reports describing
cerebral ischemia in the beach chair position have, therefore, stressed
the risk of hypotension [13]. It is often suggested that a systemic
MAP between 50 and 150 mmHg lies within the range of cerebral
autoregulation and, therefore, guarantees adequate cerebral perfusion.
However this assumption has been challenged. First, the concept of
cerebral autoregulation is questioned, because there seems to be a
considerable individual variability in the autoregulation limits [14].
Second, it has been claimed that blood pressure measured at the
brachial artery may overestimate the pressure at the level of the
brain when the sitting position is adopted. Some authors, there-
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fore, propose an arithmetic correction of blood pressure to determine
pressure at the level of the brain (1 mmHg for each 1.25 cm difference
in height between the external meatus and the middle of the blood
pressure cuff) [13]. Applying this assumption to the present study,
the mean difference between the brain and the site of the blood
pressure cuff on the arm of 31 ± 3 (24-38) cm, would overestimate
arterial pressure at the level of the head by 24 ± 2 (18-29) mmHg.
Third, cerebral perfusion pressure (CPP) depends not only on inflow
pressure but also on outflow pressure: CPP = MAP- central venous
pressure (CVP) or CPP = MAP- intracranial pressure (ICP) if ICP
is more than CVP. In the upright position, the jugular veins either
partly or fully collapse, and the vertebral venous plexus becomes the
main pathway for venous drainage [12]. Flow through this plexus
might be impeded during head rotation and head tilt.
Although intuitively one would suppose that older patients have
an increased risk of cerebral desaturation, our data showed no
difference in the response to position change with age, which is
consistent with the results of Gatto et al. [15] and Edlow et al. [16].
The cerebral circulation is very responsive to changes in CO2. In
a patient with normal CO2 reactivity, cerebral blood flow changes
1-2 ml/100g/min per mmHg change in CO2 [17]. This was also clear
in our study, which showed a lower rScO2 with lower EtCO2.
Given the positive correlations between rScO2 and blood pressure
and EtCO2, a simple recommendation could be to avoid hypotension
and low EtCO2. The study by Tange et al. [11] demonstrated that,
with appropriate measures, cerebral desaturation can be avoided.
However, three caveats should be considered. First, the ability of
the circulatory system to compensate for sudden position changes
varies considerably between patients and is unpredictable. Second, if
deliberate hypotension is required, the impact on cerebral perfusion
is unknown unless specific monitoring is employed. Finally, the high
prevalence of cerebral desaturation in this study, together with the
dramatic case reports, indicate that there is a compelling need for
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more wariness and for more specific monitoring. Due to the advantage
of simple, continuous and non-invasive monitoring, NIRS could have
the potential to optimize patient care in these situations.
Several limitations should be considered. First, because
NIRS technology does not distinguish between arterial and venous
hemoglobin saturation, changes in the proportion of cerebral arterial
and venous blood volume may confound measurements [18]. Changes
in body position affect both arterial and venous pressures and can
alter the ratio of arterial to venous compartments in the cerebral
circulation. The measured changes in rScO2 in the upright position
may, therefore, be a consequence of true changes in tissue oxygen
tension, or may be the effect of the changes in the relative frac-
tions of arterial and venous blood in the cerebral tissue. Real-time
measurements of changes in cerebral blood flow using transcranial
Doppler might be helpful in solving this question, but is difficult to
establish properly during head-up table tilting and during surgical
manipulation of the patient. Second, the prevalence of desaturation
is dependent on the baseline value and the threshold used to define
cerebral desaturation. In most clinical studies, a 20% reduction from
awake values or an absolute decrease below 50% oxygen saturation
is used as the threshold [9]. Slater et al. [8] also took the duration
of desaturation into account by introducing the term ‘desaturation
score’. Third, the relevance of the changes in cerebral oxygenation
parameters might be questioned because of the absence of gross
postoperative neurological dysfunction. However, without exten-
sive neurocognitive monitoring, subtle changes induced by cerebral
hypoxia may go unnoticed until functional organ damage becomes
evident. Several randomized controlled trials have demonstrated that
detection and treatment of cerebral oxygen desaturation results in
better clinical outcome [8, 19-21].
Finally, there is the interesting controversy with regard to the
exact determination of CPP and its relationship with flow. The
practice of correcting the blood pressure for position (raising the
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transducer or adjusting arterial pressure estimation to allow for
the height between the heart and the brain) is dictated by the
assumption that the heart lifts the blood to the elevated brain without
a corresponding and equivalent venous return limb. In a closed loop
system, such as the intact circulation, there is a continuous and
balanced fluid column and no net work is performed against the
effect of gravity [22]. Therefore, as long as the hydrostatic gradient
from the measurement site to the brain remains the same for inflow
and outflow pressures, there is no significant flow related pressure
drop between the measurement site and the brain [23]. Hence, there
is no need for adjustment of pressure measurements if the assumption
is correct that venous outflow depends only on the outflow pressure,
although this does not take into account the more complex nature
of the venous resistance and the possibility of venous collapse when
assuming the upright position. Therefore, it has been proposed that
the CPP formula should be adapted to take into account the effect
of atmospheric pressure on the jugular veins. It has been suggested
that measurement level adjustments are probably not necessary if
CVP can be maintained above 18 mmHg [24].
In conclusion, the results of the present study showed an incidence
of 80% of cerebral oxygen desaturation when the beach chair position
was adopted in patients undergoing shoulder surgery. Together with
the high prevalence of cerebral desaturation also found in other
studies, this underlines the need for awareness of this problem and
suggests the need for perioperative monitoring of cerebral tissue
oxygenation in this type of surgery. Monitoring, of course, should
not preclude all customary measures being taken to avoid an abrupt
decrease in blood pressure with position change.
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Abstract
Purpose: To describe the use of near-infrared spectroscopy (NIRS)
to identify and reverse cerebral ischemia in a patient in whom the
maintenance of adequate cerebral perfusion during cardiopulmonary
bypass (CPB) was jeopardized severely because of moyamoya disease.
Case report: In an adult patient with moyamoya disease undergoing
mitral valve repair, the use of NIRS provided real-time cerebral
oxygenation monitoring and enabled close monitoring of all
therapeutic actions taken. The decrease in rScO2 with the initiation
of CPB was reversed succesfully by the institution of pulsatile CPB
flow, whereas other standard interventions, such as the increase of
perfusion pressure and pump flow had failed, suggesting that these
patients depending on extensive collateral network brain perfusion
may benefit from preserved pulsatility during CPB.
Conclusion: This case report shows that real-time cerebral
oxygenation monitoring during CPB provides a clinical useful
additional monitoring tool, especially in patients at risk for
neurological damage by a cerebrovascular disease like moyamoya.
3.4.1 Introduction
Moyamoya disease (MMD) is a progressive, chronic cerebrovascular
occlusive disease occurring predominantly in the Asian population.
As described by Suzuki and Takaku [1] in 1969, it affects the internal
carotid arteries and anterior and middle cerebral arteries, resulting
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in compensatory collateral networks at the base of the brain. These
networks can be observed in cerebral angiography as a ‘puff of smoke’
(moyamoya means ‘cloud’ in Japanese). The clinical appearance is
marked by various cerebrovascular incidents, including intracranial
hemorrhage, transient ischemic attack (TIA), and recurrent small
strokes [2].
In MMD, the blood supply to the brain is severely compromized,
which represents a considerable challenge to the anesthesiologist
during the perioperative period. Although the management of
patients with MMD during cerebral revascularization surgery is
described widely, reports on the management of patients with MMD
undergoing cardiac surgery with cardiopulmonary bypass are limited
[3-8]. The use of near-infrared spectroscopy (NIRS) as a monitoring
tool of cerebral oxygen saturation during cardiac surgical procedures
is gaining wide acceptance; however, its potential value in the peri-
operative management of MMD patients is unknown. In this case
report, the use of NIRS to identify and reverse cerebral ischemia in
a patient with MMD during cardiac surgery is described.
3.4.2 Case report
A 26-year-old man with MMD was referred to the authors’ university
center for the treatment of grade IV mitral valve insufficiency caused
by anterior leaflet prolapse. His medical history included one TIA
and recurrent episodes of transient headaches over the past ten
years. His brother had a history of malignant hyperthermia. Be-
cause of increasing exercise intolerance and recent symptoms of
congestive heart failure, he was proposed for mitral valve surgery.
Echocardiography showed a significant prolapse of the anterior mitral
valve leaflet, resulting in a huge eccentric jet with flow reversal into
the pulmonary veins. Preoperative investigation of the associated
cerebrovascular disease by brain magnetic resonance imaging (Fig.
3.3) showed bilateral distal occlusion of the internal carotid arteries,
occlusion of the left ophthalmic artery, and a widely disrupted circle
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of Willis with an extensive collateral network. Cerebral cortex per-
fusion seemed to be best compensated in the left occipital and left
frontal cortex. Prophylactic cerebral revascularization surgery was
not done, and cardiac surgery with mitral valve repair was chosen.
Figure 3.3: Cerebral angiography demonstrating abnormal collateral
networks at the base of the brain.
Intraoperative monitoring included 5-lead ECG, invasive blood
pressure measured in the right radial artery, central venous pressure
measured via the right internal jugular vein, temperature (esophageal
and rectal), capnography and regular arterial blood gas sampling.
Additional transesophageal echocardiography completed the cardio-
vascular monitoring. We applied a bispectral index (BIS) electrode
(BIS XP; Aspect Medical Systems, Newton, MA, USA) to monitor
the depth of anesthesia and 2 NIRS sensors on the left and right
forehead (INVOS 5100; Somanetics Corporation, Troy, MI, USA) to
non-invasively measure regional cerebral oxygen saturation (rScO2).
Before induction, awake rScO2 values were 62% and 60% at
the left and right side, respectively. With preoxygenation, rScO2
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increased to 70% on both sides (Fig. 3.4). Anesthesia was induced
with diazepam 0.1 mg/kg and fentanyl 10 µg/kg. Intubation was
facilitated with rocuronium 0.9 mg/kg and the lungs were ventilated
with an air/oxygen mixture to keep arterial carbon dioxide partial
pressure (PaCO2) around 40 mmHg. Anesthesia was maintained
with additional fentanyl and diazepam doses (total dose 22 µg/kg
and 10 mg, respectively) and a continuous infusion of propofol, of
which the dosing was guided to maintain BIS values between 35 and
50 (dose range 3-5 mg/kg/h). Throughout surgery, the blood glucose
level was kept between 80 and 120 mg/dl with a continuous insulin
infusion. Between the induction of anesthesia and the initiation of
cardiopulmonary bypass (CPB), NIRS indicated a bilateral rScO2
between 57% and 75% (Fig. 3.4).
Figure 3.4: Intraoperative plot showing real-time readings of bilateral
cerebral oxygen saturation and bispectral index. rScO2: regional cerebral
oxygen saturation, BIS: bispectral index.
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CPB was performed with a nonpulsatile flow of 2.4 l/min/m2,
with hemodilution to a minimal hematocrit of 28%. Nasopharyngeal
temperature was kept between 35◦C and 36◦C. PaCO2 and PaO2 were
maintained at 40 mmHg and 350 mmHg, respectively. Alpha-stat
regulation of pH values was adopted.
A few minutes after starting CPB, a sudden decrease in rScO2
was observed on both sides to 25 to 40% (Fig. 3.5). BIS values
showed a parallel decrease, but to a lesser extent (Fig. 3.4). Mechan-
ical causes were ruled out, and intended values of hematocrit, BIS,
PaCO2, and PaO2 were confirmed. Increases in CPB flow as well
as increases in perfusion pressure with phenylephrine failed to raise
rScO2. Therefore we decided to decrease nasopharyngeal tempera-
ture to 33◦C. Initially, rScO2 seemed to improve; however, this was
very short-lasting. Finally, we converted from nonpulsatile flow to
pulsatile flow, which resulted in a gradual rScO2 increase (Fig. 3.5).
Figure 3.5: Real-time readings of bilateral cerebral oxygen saturation
and arterial blood pressure during cardiopulmonary bypass. Institution of
pulsatile flow resulted in gradual increase in cerebral oxygen saturation.
rScO2: regional cerebral oxygen saturation, BP: blood pressure, SAP:
systolic arterial blood pressure, DAP: diastolic arterial blood pressure.
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After successful weaning from CPB, bilateral rScO2 values
stabilized around 50 to 60%. Postoperatively, the patient suffered
from prolonged somnolence and a transient paresis of the left arm,
which improved over the following days without any sequelae. At post-
operative day 10, magnetic resonance imaging of the brain revealed
no new defects.
3.4.3 Discussion
This case report shows the utility of NIRS monitoring in a MMD
patient in whom the maintenance of adequate cerebral perfusion
during CPB was jeopardized severely because of the underlying
pathology.
Denault et al. [9] introduced a useful treatment algorithm to
correct decreases in cerebral saturation values, which the authors
have adopted for many years. When rScO2 decreased, technical or
mechanical causes (eg, adhesion of the NIRS sensors, head position,
and positioning of the arterial and venous cannulae) were first ruled
out. Then, those factors that affect cerebral oxygen balance, such as
blood pressure [10], PaCO2 [10], temperature [11], hematocrit [12],
depth of anesthesia [13] and pump flow, were verified and optimized.
Real-time cerebral oxygenation monitoring enabled us to monitor
closely the effects of each therapeutic action. Despite correction for
all possible confounding factors, a dramatic decrease in rScO2 values
during CPB was still observed. Finally, the decrease in rScO2 was
reversed successfully by initiating pulsatile CPB flow, as suggested
by Denault et al. [9].
The benefit of pulsatile versus nonpulsatile flow during CPB
remains an intensely debated topic. The controversy is likely because
of the heterogeneity of the study populations and the lack of quantifi-
cation of generated pressure-flow waveforms [14]. A series of studies
have documented that at the same flow and pressure conditions
pulsatile perfusion generates more hemodynamic energy in the blood
flow than nonpulsatile perfusion. This additional energy resulted in
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better vital organ perfusion [15,16]. Pulsatile CPB has been shown
to improve cerebral blood flow and brain tissue oxygenation [17].
Only 3 clinical reports documented the influence of pulsatile CPB
on rScO2 measured with NIRS. Zhao et al. [18] and Su et al. [19]
showed smaller decreases in rScO2 levels in the pulsatile versus non-
pulsatile group during pediatric CPB. In contrast, Grubhofer et al.
[20] found no benefit of pulsatile perfusion on cerebral oxygenation
during hypothermic CPB in adult patients. In the present case,
a steady increase in rScO2 was observed when pulsatile flow was
initiated, supporting the observations of Zhao et al. [18] and Su et
al. [19].
Considering the family history of malignant hyperthermia, we
avoided the use of volatile anesthetics. Several studies showed no
significant difference in outcome or perioperative complications of
inhaled anesthesia versus total intravenous anesthesia. However,
two studies [21,22] compared the effect of sevoflurane and propofol
on regional cortical blood flow and intracranial pressure during
revascularization procedures in patients with MMD and concluded
that with propofol cortical blood flow was significantly higher and
intracranial pressure was lower.
Two case reports in which BIS monitoring was applied [3,4]
and one report with NIRS monitoring [5] during cardiac surgery
in patients suffering from MMD were found, yet none used both
BIS and NIRS. In this case, dramatic decreases in NIRS values
were found, which was only mildly reflected in the associated BIS
values. Although BIS and NIRS offer distinct indices for perioperative
neurological monitoring, both are actually complementary. BIS
reflects the functional state of the brain, and therefore BIS could
help to determine the significance of a rScO2 decrease. By contrast,
because rScO2 assesses cerebral oxygen balance, it helps to identify
the cause of a BIS change. In this case report, the decrease of
BIS values could have been interpreted as an increase in depth of
anesthesia or as a decrease in cerebral metabolic rate by lowering body
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temperature. However, the associated decrease in NIRS suggested
that the reduction in BIS was caused by a cerebral oxygenation
deficit.
The limitations of NIRS are inherent to its underlying technology
and are described in detail elsewhere [23,24]. Specifically for this case,
some limitations of NIRS are highlighted. First, although the algo-
rithm used to calculate oxygen saturation assumes a fixed distance
for light to travel through the sampled area (the optical path length),
its validity remains questionable in the rapidly changing condition
occurring during CPB (eg, a decrease in hematocrit or a change
in viscosity). Second, Tyree et al. [25] showed that measurements
based on hemoglobin saturation (which is the case for NIRS) do not
always accurately reflect oxygenation at the cellular level, providing
a false sense of safety. Finally, the measurements obtained with NIRS
are regional and strictly confined to the zone underneath the sensor.
Consequently, clinically relevant focal ischemia in a brain area remote
from the monitored area may stay unnoticed, in particular in patients
with a diffuse occlusive cerebrovascular disease like MMD.
This case report shows that real-time cerebral oxygenation moni-
toring during CPB provides a clinical useful additional monitoring
tool, especially in patients at risk for neurological damage by a
cerebrovascular disease like MMD. The successful reversal of rScO2
decrease by the institution of pulsatile CPB flow, whereas other
standard interventions, such as the increase of perfusion pressure
and pump flow had failed, suggests that these patients depending
on extensive collateral network brain perfusion may benefit from
preserved pulsatility during CPB.
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Chapter 4
NIRS for monitoring
regional tissue perfusion
4.1 Background
The amount of blood delivered to an organ determines oxygen delivery
to that particular organ. Under physiological conditions, different
organs receive a relatively predictable blood flow depending on their
metabolic demand. However, when cardiac output decreases, the
sympathetic stress response raises vascular resistance, diverting blood
flow from less important tissues (skin, muscle, gastrointestinal tract,
kidneys) to vital organs (the brain and the heart). Monitoring the
macrocirculation using measures of blood pressure and arterial oxygen
saturation, do not necessarily predict adequate perfusion and oxygena-
tion of individual tissues. The use of NIRS for monitoring regional
oxygen saturation at somatic sites has been advocated as an early
warning system for changes in the oxygen supply-demand balance,
thereby allowing an early marker of silent regional hypoperfusion.
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4.2 Objective
The aim of the present studies was to explore the potential of NIRS
to monitor regional organ perfusion. In the first study, the effect of
aortic cross-clamping on cerebral, renal, and muscle oxygen saturation
was evaluated in children undergoing aortic coarctation repair. In the
second study, the applicability of NIRS to estimate oxygen saturation
of the spinal cord was explored during aortic cross-clamping in a
patient undergoing thoracoabdominal aneurysm repair.
4.3 NIRS during aortic coarctation repair
The effect of blood pressure regulation during aortic
coarctation repair on brain, kidney and muscle oxygen
saturation measured by near-infrared spectroscopy: a
randomized, clinical trial. Moerman A, Bove´ T, Franc¸ois K,
Jacobs S, Deblaere I, Wouters P, De Hert S. Anesth Analg
2013; 116: 760-6
Abstract
Background. In this study, we compared the effects of three frequently
used blood pressure-regulating agents on brain (rScO2), renal (SrO2),
and muscle (SmO2) oxygen saturation, during aortic coarctation
repair in children. Based on the reported adverse effect of sodium
nitroprusside (SNP) on left-sided rScO2 during aortic coarctation
repair, we tested the hypothesis that the alterations in left rScO2
occurring with SNP would not be present with sevoflurane and
nitroglycerin (NTG). Additionally, we explored the effects of blood
pressure regulation with SNP, NTG or sevoflurane on right-sided
rScO2, SrO2, and SmO2.
Methods. Children with isolated aortic coarctation undergoing
surgical repair through a left thoracotomy without the use of
cardiopulmonary bypass were considered eligible for the study.
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During aortic cross-clamping, control of mean arterial blood pressure
(MAP) was conducted according to randomization by the use of
SNP, NTG or sevoflurane, to obtain a mean target right brachial
blood pressure of 120 to 150% of the MAP value before cross-
clamping. Bilateral rScO2, SrO2 and SmO2 were recorded continu-
ously with near-infrared spectroscopy. As a primary endpoint, the
maximal relative change in left-sided rScO2 in response to aortic
cross-clamping was compared among treatment groups.
Results. Ten patients per group were included. No significant
difference among treatment groups was observed in maximal relative
change in left-sided rScO2 (SNP vs sevoflurane: mean difference
-0.7%, 99% confidence interval (CI) -31 to 29%, P=1.0; SNP vs NTG:
mean difference -1.8%, 99% CI -32 to 28%, P=1.0; sevoflurane vs
NTG: mean difference -1.1%, 99% CI -31 to 29%, P=1.0). Additional
analyses also detected no difference between groups in right rScO2
(P=0.4). Compared with NTG, treatment with SNP resulted in a
significantly larger (-64 ± 17 vs -34 ± 25%, P=0.01) and faster (-9
± 4%.min−1 vs -4 ± 3%.min−1, P=0.004) decrease in SmO2. Right-
sided rScO2 and MAP showed a poor correlation for NTG (r=-0.2,
P=0.93), whereas borderline for sevoflurane (r=0.44, P=0.09) and
SNP (r=0.56, P=0.04).
Conclusions. The mean differences in left-sided rScO2 among
the patients treated with SNP, NTG, or sevoflurane for proximal
hypertension during aortic cross-clamping were no more than 32%.
Additional analysis demonstrated a low MAP-rScO2 dependence
with the use of NTG. Because NTG also resulted in a smaller and
slower decrease of oxygen saturation in peripheral tissues, our data
suggest that its use might be preferable for proximal blood pressure
control during surgical procedures involving aortic cross-clamping.
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4.3.1 Introduction
Surgical repair of aortic coarctation through left thoracotomy involves
proximal aortic arch cross-clamping, resulting in temporary hypoper-
fusion of the tissues distal to the cross-clamp. This manoeuver may
also be associated with an abrupt increase in ventricular afterload
and immediate proximal (to the aortic cross-clamp) hypertension,
often necessitating pharmacologic control [1]. Currently, the use of
potent and short-acting vasodilators such as sodium nitroprusside
(SNP) and nitroglycerin (NTG) is preferred for treating hypertension
during aortic cross-clamping for this procedure. However, Azakie
et al. [2] have raised concerns regarding the effect of SNP on left-
sided cerebral oxygen saturation (rScO2) during aortic coarctation
repair. In addition, it has been demonstrated that SNP may worsen
the already impaired oxygen balance of tissues below the aortic
cross-clamp during surgery on the thoracic aorta [3-5].
The effects of different antihypertensive agents on tissue oxygen
saturation during aortic cross-clamping remain largely unexplored.
The purpose of the present study was to test the hypothesis that the
alterations in left rScO2 described with SNP would not be present
with other blood pressure-regulating agents. Second, we wanted to
compare the effects of blood pressure-regulating drugs during aortic
coarctation repair on the oxygen saturation of the right-sided brain
and the peripheral tissues.
Three agents frequently used for perioperative blood pressure
control during cardiac surgery [6] were included: SNP and NTG
as intravenous vasodilating agents, and sevoflurane as an inhaled
anesthetic with vasodilating effect. We hypothesized that the
alterations in oxygen saturation of the brain and peripheral tissues
reported with SNP would represent an agent-specific phenomenon
that is not present with NTG or sevoflurane.
4.3. NIRS DURING AORTIC COARCTATION REPAIR 75
4.3.2 Methods
This study was a single-center, prospectively randomized, controlled
trial, conducted from October 2007 to March 2011. The
trial was registered at ClinicalTrials.gov, on September 25, 2007
(NCT00535808). After Institutional Review Board approval, written
informed consent was obtained from the parents or legal guardian of
the child.
All children with isolated aortic coarctation undergoing surgical
correction through a left thoracotomy without the use of cardiopul-
monary bypass were considered eligible. Patients with associated
cardiac defects resulting in a hemodynamically significant intra-
cardiac shunt were excluded. To assure uniformity of the impact
of aortic cross-clamping on cerebral perfusion, the experimental
protocol involved cross-clamping of the left carotid artery in all
patients. If cross-clamping of the left carotid artery was surgically
not indicated, patients were excluded from the study protocol. As-
signment to the groups was determined by random drawing of sealed
envelopes containing the labels ‘sevoflurane’, ‘sodium nitroprusside’
or ‘nitroglycerin’.
On the morning of the surgery, patients were allowed to take their
normal daily medication. The uniform protocol of anesthesia included
induction with sufentanil 0.5 µg/kg, midazolam 100 µg/kg, and
rocuronium 0.9 mg/kg. Anesthesia was maintained with sevoflurane
inhalation (1 MAC) and additional doses of sufentanil. Mechanical
ventilation was adjusted in order to obtain an arterial carbon dioxide
partial pressure (PaCO2) of 40 mmHg. Fractional inspired oxygen
(FiO2) was set at 0.5. The body temperature was kept constant at
35.0-36.0 ◦C by using a warming mattress underneath the patient
(Blanketrol R© II, Cincinnati Sub-Zero Products Inc., Cincinnati, OH)
and a pediatric forced-air warming blanket surrounding the patient
(Bair Hugger R© Therapy, Arizant Healthcare Inc., Eden Prairie, MN).
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Two disposable near-infrared spectroscopy (NIRS) sensors were
applied on each side of the forehead for continuous registration of
the rScO2 of the corresponding brain hemisphere (INVOS 5100,
Somanetics Corporation, Troy, MI). Additionally, a NIRS sensor was
placed over the right flank below the costovertebral angle overlying
the kidney (T10-L2) to estimate renal oxygen saturation (SrO2), and
one over the right thigh to measure muscle oxygen saturation (SmO2).
Arterial blood pressure was recorded continuously via an arterial line
in the right brachial artery. A blood pressure cuff was placed on the
left lower extremity. Central venous pressure was monitored through
right internal jugular vein access.
The surgical procedure was performed in a standardized manner,
with the patient in the right lateral decubitus position, using a
left lateral thoracotomy approach. After extensive dissection of
the aortic arch, supra-aortic vessels and descending aorta down to
four intercostal levels, the ductus arteriosus or ligament was ligated.
Subsequent to systemic heparin administration (1 mg/kg), the aortic
arch was cross-clamped proximally between the innominate artery
and the left carotid artery, and distally on the descending aorta below
the first intercostal artery. Surgical repair consisted of resection of
the coarctation segment and direct end-to-end anastomosis.
Control of blood pressure during aortic cross-clamping was
performed according to the randomization sequence by the use of
sevoflurane, SNP or NTG. Drug dose was titrated to obtain a mean
target right brachial blood pressure of 120 to 150% of the mean
blood pressure value before aortic cross-clamping. The vasodilator
therapy was started immediately after heparin administration (start
of administration of SNP/NTG in the SNP and NTG groups, respec-
tively, or increasing the concentration of sevoflurane in the sevoflurane
group). Two minutes before anticipated completion of the anasto-
mosis, administration of the vasoactive treatment was stopped to
attenuate the hypotensive response upon clamp release.
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Heart rate, invasive systemic blood pressure and central venous
pressure, in- and end-expiratory gas tensions, pulse oximetry and
NIRS data (bilateral rScO2, SrO2, SmO2) were recorded continu-
ously and integrated digitally with the RUGLOOP software (Demed,
Temse, Belgium). Analysis of hematocrit, arterial and venous blood
gas partial pressures, and lactate levels was performed just before
surgical incision, after heparin administration, 5 min after aortic
cross-clamping, 5 min after aortic declamping, and postoperatively
at arrival in the intensive care unit. Types and volumes of all fluids
administered, doses of any drugs given, and blood loss were recorded.
Data description
In the present study, we compared the effects of three blood
pressure-regulating agents on rScO2, SrO2, and SmO2. Because no
data from the literature were available allowing sample size calcula-
tion for changes in SrO2 and SmO2 during aortic cross-clamping, we
had to rely for the expected treatment effects and the sample size
calculation on reported rScO2 changes during aortic cross-clamping.
Azakie et al. [2] demonstrated a relative decrease of left-sided rScO2
of 10.4% with the use of SNP during aortic cross-clamping. Assum-
ing a baseline mean rScO2 and standard deviation of 71% and 6%,
respectively [7], a sample size of 7 patients per group was calculated
to detect a minimal difference of 10% in left rScO2 among treatment
groups with a power of 0.8 and an α of 0.05. To account for possible
dropouts, 10 patients per group were included.
Absolute NIRS values have a wide range of variability among
patients when measured with the INVOS technology [8]. Therefore,
only measures of the relative changes in NIRS variables were analyzed,
defined as the relative percentage of the lowest (in case of decrease)
or highest (in case of increase) value during the cross-clamp period
versus the value just before aortic cross-clamping.
The primary outcome variable of the present study was the
maximal relative change in left rScO2 after aortic cross-clamping.
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Secondary NIRS variables included the maximal relative change in
right rScO2, SrO2 and SmO2 after aortic cross-clamping. Further
secondary analyses included the rate of decrease in SrO2 and SmO2
in each treatment group, and the integrated rScO2, SrO2, and SmO2
for each treatment group. The rate of decrease in SrO2 and SmO2
was determined by the average rate of decay, calculated by dividing
the maximal change in SrO2 or SmO2 by the time to reach its nadir,
expressed in % per minute. The integrated rScO2, SrO2, or SmO2,
or area under the curve (AUC), was calculated with reference to the
value just before aortic cross-clamping, using measurement intervals
of 5 seconds, and is expressed in %.second. Subsequently, the AUC
accounts for both depth and duration of change in oxygen saturation.
Since rScO2 and blood pressure have been reported to be
correlated [9], we also evaluated the relationship between right-sided
rScO2 and MAP in the 3 treatment groups.
The extent of collateral circulation has been shown to be age-
related [10], therefore the relationship between age and changes in
SrO2 and SmO2 was also evaluated.
Statistical analysis
Statistical analysis was performed using the statistical software
SPSS Statistics 20 (SPSS Inc., Chicago, IL). The raw data were
tested for normality using the Shapiro-Wilk test and were considered
normally distributed if P > 0.05. Homogeneity of variances was
tested with Levene’s test. Additionally, residuals were tested as well,
and normality has been confirmed. Normally distributed continuous
data are presented as mean ± SD. Non-parametric data are presented
as median [range].
Comparison of demographic data among the 3 treatment groups
was performed with the Kruskal-Wallis test for continuous data and
with the chi-square test for categorical data.
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Intraoperative data, absolute rScO2, SrO2 and SmO2 values, and
blood gas values among the 3 treatment groups were compared with
analysis of variance. For pairwise comparisons among groups, Tukey
correction was used with 99% confidence intervals (CIs).
Between-group comparisons of maximal relative changes in rScO2,
SrO2, and SmO2 were done in a general linear model with adjustment
for baseline oxygen saturations, and Bonferroni correction for multiple
comparisons (3 in the Bonferroni denominator). The same statistical
method was applied for analysis of the rate of decay for SrO2 and
SmO2.
AUCs for rScO2, SrO2 and SmO2 were analyzed with the Kruskal-
Wallis test. Pairwise differences in AUC among treatment groups
were examined for significance by using Mann-Whitney U test.
For the correlation between changes in right rScO2 and MAP,
Kendall’s tau test of concordance was used. The relationship between
age and changes in SrO2 and SmO2 was evaluated by simple linear
regression analysis.
The level of statistical significance was set at corrected 2-sided
P-value <0.05 for the primary analyses. A P-value of <0.01 was
considered significant for secondary endpoints regarding multiple
comparisons after Bonferroni correction with denominator 3.
4.3.3 Results
Thirty-one patients were considered eligible. One patient was
excluded before randomization to a treatment group because cross-
clamping of the left carotid artery was surgically not indicated.
Patient characteristics are summarized in Table 4.1. There were no
differences among groups in the listed variables.
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Table 4.1: Patient characteristics for the three randomized groups
Sevo SNP NTG P-value
Gender (M/F) 7 / 3 8 / 2 6 / 4 0.62
Age (days) 12 [4–193] 20 [3–77] 90 [5–568] 0.36
Weight (kg) 3.3 [2.0–8.6] 3.6 [1.4–5.7] 5.1 [3.2–11.3] 0.22
BSA (m2) 0.21 [0.15–0.39] 0.22 [0.12–0.28] 0.27 [0.20–0.49] 0.20
ASA 1/2/3 (n) 0/5/5 0/6/4 1/4/5 0.92
Data are expressed as median [range]. M/F: Male/Female, ASA: American
Society of Anesthesiology, BSA: body surface area, NTG: Nitroglycerin,
Sevo: sevoflurane, SNP: Sodium Nitroprusside.
Intraoperative data are reported in Table 4.2. As expected, during
aortic cross-clamping, the mean end-tidal sevoflurane concentration
was higher in the sevoflurane group compared with the SNP group
and the NTG group (P=0.01 for each). There was no difference
in sevoflurane concentration between the SNP and NTG groups.
Sufentanil total dose and arterial and venous blood gas results were
similar among the three groups. The mean total doses of SNP and
NTG necessary for maintaining the target MAP were 14.3 ± 11.2
µg/kg and 18.6 ± 14.5 µg/kg, respectively.
No significant differences in MAP were observed among the 3
groups at any time of measurement, indicating that the different blood
pressure-regulating strategies allowed for a comparable proximal
blood pressure control during aortic cross-clamping.
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Table 4.2: Intraoperative data for the three randomized groups
Sevo SNP NTG P-value
Duration of CX 15 ± 5 13 ± 5 15 ± 10 0.79
(min)
Total sufentanil dose 1.5 ± 0.3 1.7 ± 0.6 1.9 ± 0.8 0.34
(µg/kg)
Mean ETsevo 3.1 ± 1.1 1.8 ± 0.6* 1.8 ±0.5* 0.01
during CX (%)
Mean MAP during CX 61 ± 11 69 ± 15 70 ± 19 0.43
(mmHg)
Mean HR during CX 123 ± 10 128 ± 17 126 ± 17 0.73
(beats/min)
Hct during CX 31 ± 4 32 ± 4 31 ± 6 0.94
(%)
PaO2 during CX 145 ± 42 151 ± 67 156 ± 67 0.93
(mmHg)
PvO2 during CX 41 ± 14 46 ± 11 50 ± 14 0.34
(mmHg)
PaCO2 during CX 44 ± 5 47 ± 8 44 ± 9 0.76
(mmHg)
Lactate during CX 19 ± 5 18 ± 4 15 ± 4 0.35
(mg/dl)
Data are expressed as mean ± SD. Analysis of hematocrit, blood gas partial
pressures and lactate was performed 5 minutes after start of aortic
cross-clamping (CX). *P=0.01 for the difference with the sevoflurane group. CX:
aortic cross-clamping, ETsevo: end-tidal concentration of sevoflurane, Hct:
hematocrit, HR: heart rate, MAP: mean arterial pressure, NTG: Nitroglycerin,
Pa: arterial partial pressure, Pv: venous partial pressure, Sevo: sevoflurane,
SNP: Sodium Nitroprusside.
82 CHAPTER 4. NIRS AND REGIONAL PERFUSION
No difference among groups was observed in mean left-sided
rScO2 values before aortic cross-clamping (72 ± 10%, 77 ± 13%,
and 77 ± 11% for sevoflurane, SNP and NTG, respectively, P=0.57).
Three possible responses to aortic cross-clamping were observed in
left rScO2 measurements: a decrease of left rScO2 in 2 patients of
each group (maximal relative decrease of -5 and -17% for sevoflu-
rane, -5 and -47% for SNP, -28 and -33% for NTG, P=0.58 between
groups), no change in left rScO2 in 1 patient in the sevoflurane group,
2 patients in the SNP group, and in 2 patients in the NTG group,
whereas an increase in left rScO2 was observed in the remaining
patients (sevoflurane, n= 7, 10 ± 7%; SNP, n=6, 13 ± 4%; NTG,
n=6, 17 ± 19%, P=0.32 between groups). No differences among
groups were observed in the maximal relative changes in left rScO2
values in response to aortic cross-clamping (SNP vs sevo: mean
difference -0.7%, 99% CI -31 to 29%, P=1.0; SNP vs NTG: mean
difference -1.8%, 99% CI -32 to 28%, P=1.0; sevo vs NTG: mean
difference -1.1%, 99% CI -31 to 29%, P=1.0).
The following additional observations were made regarding
changes in right rScO2, SrO2 and SmO2. No differences among
groups were observed in mean right rScO2 values before aortic cross-
clamping (P=0.69) and in maximal relative change in right rScO2
values in response to aortic cross-clamping (P=0.4) (Table 4.3). SrO2
and SmO2 showed a rapid and significant decrease after aortic cross-
clamping in all groups, reaching a plateau phase for SrO2 within
8.6 minutes, 7.4 minutes and 10.0 minutes for sevoflurane, SNP, and
NTG, respectively (P=0.08 among groups) and within 9.4 minutes,
6.8 minutes and 9.9 minutes for SmO2 for sevoflurane, SNP, and NTG,
respectively (P=0.02 among groups). All tissue oxygen saturations
recovered promptly after release of the aortic cross-clamp. For SmO2,
the maximal relative changes were larger and the rate of decay was
faster in the SNP group compared to the NTG group (Table 4.3).
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Table 4.3: Absolute values before aortic cross-clamping and maximal
relative change during aortic cross-clamping for right cerebral (rScO2), renal
(SrO2) and muscle oxygen saturation (SmO2) for the three randomized
groups. Rate of decay during aortic cross-clamping for SrO2 and SmO2 for
the three randomized groups
Sevo SNP NTG P-value
Absolute right rScO2
value (%) before CX 70 ± 13 72 ± 12 74 ± 8 0.69
Maximal relative change
in right rScO2 (%) 18 ± 18 21 ± 14 14 ± 12 0.40
Absolute SrO2 value (%)
before CX 77 ± 8 82 ± 9 70 ± 16 0.13
Maximal relative change
in SrO2 (%) -43 ± 19 -59 ± 13 -33 ± 22 0.04
Rate of decay SrO2
(%.min−1) -6 ± 3 -8 ± 3* -4 ± 3 0.01
Absolute SmO2 value (%)
before CX 81 ± 13 78 ± 13 79 ± 16 0.92
Maximal relative
change in SmO2 (%) -55 ± 19 -64 ± 17* -34 ± 25 0.01
Rate of decay SmO2
(%.min−1) -6 ± 2 -9 ± 4* -4 ± 3 0.004
Data are expressed as mean ± SD. CX: aortic cross-clamping, NTG:
Nitroglycerin, Sevo: sevoflurane, SNP: Sodium Nitroprusside.
*Significantly different (p<0.01) from NTG group.
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AUC for oxygen saturation from each site is depicted in Fig.
4.1. No differences were observed among the 3 treatment groups
in AUC for left-sided and right-sided rScO2 (P=0.74 and P=0.17,
respectively). For renal AUC, there was a difference between the
NTG and the SNP group (P=0.009). There were no differences
in muscle AUC among the treatment groups (P=0.05 for NTG vs
sevoflurane, and P=0.03 for NTG vs SNP).
Figure 4.1: Box-and-whisker plots of the area under the curve (AUC) for
cerebral, renal and muscle oxygen saturation. NTG: Nitroglycerin, Sevo:
sevoflurane, SNP: Sodium Nitroprusside. ◦: outliers of the 5% and 95%-
centiles. P-values presented in the figure below each measurement indicate
between groups differences analyzed with the Kruskal-Wallis test. Pairwise
differences between treatment groups were analyzed with Mann-Whitney
U test (*SNP vs NTG, p=0.009).
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Right-sided rScO2 and MAP showed a poor correlation for
NTG (r=-0.2, P=0.93), whereas the correlation was borderline for
sevoflurane (r=0.44, P=0.09) and SNP (r=0.56, P=0.04).
An effect of age was observed on the maximal relative decrease
of SrO2 (unstandardized β=0.06, CI 99% -0.02 to 0.14, P=0.06) and
SmO2 (unstandardized β=0.07, CI 99% 0.01 to 0.13, P=0.03). This
effect was independent of the study product used (unstandardized
β=1.5, CI 99% -12.4 to 15.4, P=0.76 for SrO2 and unstandardized
β=6.3, CI 99% -7.9 to 20.6, P=0.23 for SmO2).
Analysis of hematocrit, blood gas partial pressures, and lactate
levels performed 5 minutes after aortic cross-clamp removal is
presented in Table 4.4. There were no differences among the
treatment groups. In all patients, clinical recovery was unevent-
ful. Postoperative lactate levels and blood creatinine levels were
comparable among groups.
Table 4.4: Analysis of blood gas values performed 5 minutes after aortic
cross-clamp removal for the three randomized groups
Sevo SNP NTG P-value
pH 7.26 ± 0.07 7.27 ± 0.12 7.33 ± 0.09 0.24
Base excess (mmol/L) -4.4 ± 2.3 -3.2 ± 4.0 -2.5 ± 3.3 0.45
Bicarbonate (mmol/L) 22.1 ± 1.2 23.9 ± 3.3 23.3 ± 2.9 0.31
Hct (%) 31 ± 4 32 ± 3 32 ± 5 0.78
PaO2 (mmHg) 172 ± 89 175 ± 88 164 ± 63 0.95
PvO2 (mmHg) 51 ± 8 49 ± 6 47 ± 8 0.54
PaCO2 (mmHg) 51 ± 6 55 ± 15 46 ± 9 0.20
Lactate (mg/dl) 29 ± 8 24 ± 8 21 ± 7 0.11
Data are expressed as mean ± SD. Hct: hematocrit, NTG: Nitroglycerin, PaO2:
partial pressure of oxygen, arterial, PvO2: partial pressure of oxygen, venous,
Sevo: sevoflurane, SNP: Sodium Nitroprusside.
86 CHAPTER 4. NIRS AND REGIONAL PERFUSION
4.3.4 Discussion
In this randomized, clinical study, the effects of blood pressure-
regulating strategies with SNP, NTG, or sevoflurane on cerebral,
renal and muscle oxygen saturation were investigated during aortic
cross-clamping in children undergoing aortic coarctation repair. No
significant differences in cerebral oxygen saturation values were ob-
served among the three strategies. Decreases in renal and muscle
oxygen saturation were larger and had a faster rate of decay in
SNP-treated patients. For both SNP and sevoflurane MAP-rScO2
dependence was higher than for NTG.
Effects on cerebral oxygen saturation
In this study, aortic cross-clamping always involved temporary
occlusion of the left carotid artery. This manoeuver was associated
with a variable response of the left-sided rScO2, ranging from a
decrease to an increase in rScO2. Confidence intervals for pairwise
comparisons between groups were wide. Although our study design
did not allow us to comment on possible underlying mechanisms, it
is conceivable that this phenomenon merely reflects the functional
adequacy of the circle of Willis.
In a study on 18 patients undergoing aortic coarctation repair,
Azakie et al. [2] observed a pronounced decrease in left rScO2
in 2 patients treated with SNP, in whom the left carotid artery
was clamped during the intervention. They attributed this finding
to a SNP-induced disruption of cerebral autoregulation. However,
because in that study no simultaneous recording of both left and
right hemispheres was obtained, it cannot be determined whether
this rScO2 decrease is the result of an agent-specific effect or rather
a deficient circle of Willis.
We observed no significant differences in right rScO2 values among
the different blood pressure-regulating strategies; however, with NTG
treatment, changes in rScO2 were less dependent on changes in MAP
than with SNP and sevoflurane. A higher correlation between MAP
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and rScO2 has been reported to be indicative of impaired cerebral
autoregulation, whereas values around zero and negative values could
be considered as representative of intact autoregulation [11,12]. In
line with this reasoning, the higher correlation between MAP and
rScO2 in the SNP and sevoflurane groups compared with the NTG
group would suggest that SNP and sevoflurane may interfere to a
larger extent with cerebral autoregulation than NTG. This is in
accordance with previous work reporting on dose-dependent impair-
ment of cerebral autoregulation with SNP [13], whereas there was
no significant impairment with NTG [14,15]. Data on the effect
of sevoflurane on cerebral autoregulation are controversial. It is
generally assumed that cerebral autoregulation is maintained at low
concentrations of sevoflurane, whereas higher doses seem to decrease
autoregulatory capacity [16].
Effects on renal and muscle oxygen saturation
Concerning the effects on peripheral tissue oxygen saturation, a
larger and faster decrease in both renal and muscle oxygen saturation
was observed in children treated with SNP. Previous studies have
suggested that SNP-induced hypotension might worsen the impaired
oxygen balance of tissues below the aortic cross-clamp [3-5]. These
findings could not be readily explained. Of interest, an experimen-
tal study on striated hamster muscle conducted by Endrich et al.
[17] demonstrated that SNP dilated preferentially precapillaries and
caused a consistent increase in intravascular pressure within the
venules. Consequently, the arteriolar-venular pressure gradient was
reduced and functional capillary density decreased, leading to skeletal
muscle tissue hypoxia. In contrast, NTG dilated both arterioles
and venules, leaving the functional capillary density and local pO2
unchanged. Our findings are in accordance with the results of Endrich
et al. [17] and suggest that NTG may be preferable to SNP in terms
of tissue oxygenation.
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In all patients, both SrO2 and SmO2 declined to a plateau phase,
which indicated that oxygen delivery no longer met metabolic oxygen
requirements, likely resulting in anaerobic metabolism. The duration
of the nadir of oxygenation has been demonstrated to be directly
related to the extent of tissue injury [18,19]. Sakamoto et al.[18]
demonstrated that nadir times of less than 25 minutes did not induce
tissue injury. It can therefore be expected that the nadir times in
our study were too short to translate into changes of biomarkers
indicative for tissue injury, such as serum lactate, base excess, and
creatinine levels.
Study limitations
The results of the present study should be interpreted within
the constraints of the methodology. First, because of absence of
evident adverse clinical events due to the short aortic cross-clamp
times, the clinical implications of the current study on outcome
remain to be determined. Second, the current study population
comprised only young patients. Because the extent of collateral
circulation has been shown to be age-related [10], the validity of
the current results in older patients with a possibly more developed
collateral circulation needs to be confirmed. Third, the reliability of
NIRS to measure specific renal oxygen saturation can be questioned
because of the uncertainty related to the depth of penetration of the
near-infrared light in relation to the kidney. However, a number of
studies have suggested that placement of a NIRS sensor over the
flank might indeed reflect renal oxygen saturation. Ortmann et al.
[20] demonstrated a strong correlation between flank NIRS values
and renal vein saturation in children weighing <10 kg. Also, low
renal tissue oxygen saturations measured with NIRS were associated
with renal dysfunction after pediatric cardiac surgery [21] and after
aortic coarctation repair [22].
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In conclusion, no differences were observed in rScO2 values
between the different blood pressure regulating strategies. How-
ever, with NTG treatment, changes in rScO2 were less dependent
on changes in MAP than with SNP and sevoflurane. Decreases
in SrO2 and SmO2 were larger and had a faster rate of decay in
SNP-treated patients. Based on the lower MAP-rScO2 dependence
and the smaller and slower decreases in SrO2 and SmO2, our data
suggest that NTG might be preferable for blood pressure control
during surgical procedures involving aortic cross-clamping.
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4.4 NIRS during aortic aneurysm repair
Near-Infrared Spectroscopy for Monitoring Spinal Cord
Ischemia during Hybrid Thoracoabdominal Aortic
Aneurysm Repair. Moerman A, Van Herzeele I,
Vanpeteghem C, Vermassen F, Franc¸ois K, Wouters P.
J Endovasc Ther 2011; 18: 91-5
Abstract
Purpose: To describe a simple, non-invasive technique to detect
changes in oxygen saturation at the level of the spinal cord and to
suggest its suitability for individualized blood pressure management
during and after thoracoabdominal aneurysm repair.
Case report: Near-Infrared Spectroscopy (NIRS) sensors were applied
over the tenth thoracic vertebra for continuous monitoring of tissue
oxygen saturation (SsO2) during endovascular repair of a post-
dissection aneurysm of the aortic arch and descending aorta. After
stent-graft deployment mean SsO2 decreased significantly. Moreover
the relationship between SsO2 and arterial blood pressure became
linear, reflecting pressure-dependency of spinal cord perfusion after
stent deployment.
Conclusion: These data show that NIRS monitors changes in
SsO2 after aortic endograft deployment which were strongly related
to arterial blood pressure. Regional NIRS monitoring at the
vertebral level may function as a valuable non-invasive guide to the
management of blood pressure during thoracoabdominal aneurysm
repair, both intra- and postoperatively.
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4.4.1 Introduction
During thoracoabdominal aortic aneurysm (TAAA) repair, spinal
cord perfusion is precarious and vulnerable to hemodynamic
compromise, eventually leading to neurologic injury [1,2]. Close
monitoring is mandatory to detect spinal cord ischemia in time to
treat it. Near-Infrared Spectroscopy (NIRS) is a non-invasive contin-
uous monitoring technique to measure tissue oxygen saturation [3].
Whereas initial research focused on the use of NIRS for monitoring
cerebral saturation, interest has now extended to evaluating the
oxygenation of tissues other than the brain. To date, research on
the use of NIRS to monitor spinal cord oxygenation is scarce: Only
animal studies [4,5] and 3 clinical reports [6-8] have examined the
feasibility of NIRS to monitor spinal cord perfusion.
We present a case where tissue oxygen saturation at the level of
the spinal cord (SsO2) decreased significantly after aortic endograft
deployment and became strongly related to arterial blood pressure.
4.4.2 Case report
A 53-year old man with an extensive medical history, including re-
placement of the aortic valve and ascending aorta (Bentall procedure)
for acute aortic dissection in 1998 and replacement of the ascending
aorta and proximal aortic arch for acute aortic dissection in 2008,
presented with a large TAAA due to chronic dissection from the
distal aortic arch into the iliac arteries. The patient was scheduled
for a staged hybrid repair. In the first phase, extra-anatomical revas-
cularization of the supra-aortic arteries from the proximal ascending
aorta was done, followed by placement of endografts in the distal
ascending aorta, aortic arch, and descending aorta. In the second
phase, open abdominal repair with retrograde perfusion of the celiac,
mesenteric, and renal arteries was planned, with further exclusion of
the TAAA by stent-grafting. Local Ethics’ Committee approval and
written informed consent from the patient were obtained.
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The hybrid arch procedure was performed under general anesthe-
sia with full hemodynamic monitoring. A cerebrospinal fluid (CSF)
drain was positioned at a height of 13.5 cmH2O above the external
meatus, which equated to a pressure of 10 mmHg within the spinal
canal. CSF was allowed to drain continuously. Disposable NIRS
sensors were applied to the right and the left side of the forehead,
over the tenth thoracic vertebra (T10), and over the right calf, and
tissue oxygen saturation was monitored continuously during the
entire procedure (INVOS 5100; Somanetics Corporation, Troy, MI,
USA). All hemodynamic, respiratory and tissue oxygen saturation
data were recorded continuously with RUGLOOP (Demed, Temse,
Belgium).
The extra-anatomical revascularization of the arch vessels was
carried out through a median sternotomy. The arch vessels were
anastomosed to a bifurcated graft that was sewn proximally onto the
ascending aortic tube graft. Epicardial ventricular pacemaker wires
were placed to allow induction of hypotension by rapid ventricular
pacing during deployment of the stent-grafts. Subsequently, the
Excluder TAG devices (W. L. Gore & Associates, Inc, Flagstaff,
AZ, USA) were delivered via the right common femoral artery. A
TAG (37× 200 mm) was introduced and deployed distal to the arch
vessels origin; a second stent-graft (37× 150 mm) was deployed with
sufficient overlap in the descending thoracic aorta, but during removal
of the delivery device, this stent-graft was accidentally withdrawn.
Retrieval of the misdeployed stent-graft (still connected to the release
wire and the inner shaft of the delivery device) was accomplished via
an infrarenal aortotomy. The infrarenal abdominal aortic aneurysm
was repaired with a bifurcation graft (Dacron 18× 9 mm) connected
to both common iliac arteries. Finally, a TAG (37× 150 mm) was
deployed uneventfully in the residual descending thoracic aorta with
sufficient overlap, terminating proximal to the diaphragm.
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Mean SsO2 decreased significantly from 76 ± 2.6% (from start
of measurement until deployment of first stent-graft) to 61± 5.6%
(from deployment of last stent-graft until the end of the operation)
(P<0.001) (Fig. 4.2).
Figure 4.2: Relationship between spinal saturation (SsO2) and mean
arterial blood pressure (MAP) before and after stent-graft deployment
during first operation.
Prior to stent-graft deployment, mean SsO2 fluctuated only mildly
with mean arterial blood pressure (MAP), while after stent-graft
deployment, small decreases in arterial blood pressure provoked major
decreases in SsO2. This pressure dependency is quantified in Figure
4.3: the correlation between MAP and SsO2 was clearly linear after
deployment of the devices, whereas there was no correlation before
stent-graft deployment.
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Figure 4.3: Correlation between spinal saturation (SsO2) and mean
arterial blood pressure (MAP) before and after stent-graft deployment
during first operation.
Twelve days later, the second part of the hybrid procedure was
performed. A spinal drain was inserted and NIRS sensors were placed
over the left and right forehead and at 2 locations over the spinal
column: at T10 and at the second lumbar vertebra (L2). The visceral
vessels were revascularized by the implantation of a bifurcated Dacron
graft anastomosed to the previously implanted bifurcated graft. The
right limb was connected to the common hepatic artery and tunnelled
behind the pancreas; the left limb was anastomosed to the superior
mesenteric trunk. Finally, a Dacron graft originating from the right
limb was connected in an end-to-end fashion to the right renal artery.
The remaining TAAA was excluded by deployment of 3 stent-grafts
with sufficient overlap (TAG 28×150 mm, 31×150 mm and 37×150
mm). Hypotension to prevent movement of the stent-grafts during
deployment was accomplished with nitroprusside. The devices were
deployed in a retrograde fashion and positioned proximal to the
bifurcated graft perfusing the visceral arteries.
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Correlation between MAP and SsO2 revealed that spinal cord
perfusion had become less pressure dependent in the days following
the first operation (r2=0.29 vs r2=0.56 immediately after first
operation) (Fig. 4.4).
Figure 4.4: Correlation between spinal saturation (SsO2) at T10 level and
mean arterial blood pressure (MAP) before and after stent-graft deployment
during second operation.
Despite very low systemic blood pressures, SsO2 at the T10 and
L2 levels remained unaffected before stent-graft deployment (Fig.
4.5). After endograft release, the pressure dependency of spinal cord
perfusion was again manifested at the T10 level, consistent with
the observation made in the first operation. However, this time an
additional measurement at L2 served as control; at the L2 level, this
phenomenon was not seen.
The patient recovered without any neurological dysfunction and
his TAAA has been succesfully excluded over 9 months of follow-up.
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Figure 4.5: Relationship between spinal saturation (SsO2) at the T10 and
L2 level and mean arterial blood pressure (MAP) during second operation.
Asterisk (*) represents stent-graft deployment.
4.4.3 Discussion
During endovascular TAAA repair, tissue oxygen saturation at the
T10 level dropped significantly after endograft deployment. Further-
more, a significant linear relationship was noted between SsO2 and
arterial blood pressure after stent-graft deployment, which was not
present before stent-graft deployment. As NIRS seems to reflect
pressure dependence of spinal cord perfusion, its utility as a guide
to optimize perioperative blood pressure management during TAAA
repair deserves further investigation.
NIRS exploits the fact that biological tissues, including bone,
are transparent in the near-infrared range [3]. Specific wavelengths
of near-infrared light are emitted through the tissues lying below
a sensor. Depending on the amount of light reflected back to light
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detectors built into the same sensor, regional oxygen saturation of
the underlying tissue can be determined. The mean depth of light
transmission is proportional to the emitter-detector separation by a
factor of approximately one third [9]. The use of 2 photodetectors
allows selective measurement of deeper tissue, a process known as
spatial resolution: the closer receiver measures superficial tissue while
the distal optode measures both superficial and deeper tissue. After
adjusting for interference from the superficial tissues, oxygenation of
deeper tissues is derived.
Initial animal studies demonstrated the feasibility of NIRS to
monitor the spinal cord. Macnab et al. [4] exposed the posterior
elements of the spine in 3 pigs; they sutured NIRS optodes directed to-
ward the spinal cord over the T9 laminae or on the spinous processes
of T9 and T10. Interventions included decreasing the arterial oxygen
saturation and distracting the spine at T9-T10, which reduced blood
flow to the spinal cord. Each intervention resulted in NIRS changes
that were observed immediately and resolved promptly, independent
of the position of the optodes. LeMaire et al. [5] sequentially ligated
segmental arteries from T6 through L1 in pigs, while regional oxygen
saturation was monitored with NIRS in the upper (T6-T7) and lower
cord (T9-T11). After ligation, regional oxygen saturation in the lower
cord was significantly less than in the upper cord. This regional dif-
ference in the degree of ischemia was confirmed microscopically, with
significantly more pronounced ischemic changes and more ischemic
neurons in the lower-cord sections.
To date, 3 reports have described the use of NIRS for monitoring
spinal cord oxygenation in humans. Macnab et al. [6] used NIRS
in an infant requiring release of a congenitally tethered spinal cord.
Subsequently, in a series of 9 patients undergoing TAAA repair,
Edmonds and Ganzel [7] observed a greater decline in spinal sat-
uration measured at T10 in patients who experienced lower limb
motor deficit compared to patients without deficit. This decline
was consistent with the results of simultaneously performed spinal
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cord transmission measurements. Mitchell et al. [8] noted a signifi-
cant drop in perispinal regional oxygen saturation at the T10 level
during coarctation repair in neonates. Removal of the aortic clamp
immediately restored the perispinal saturation to baseline values.
In NIRS monitoring of spinal cord ischemia, the optically inter-
rogated region is not well-defined, which may pose a problem. One
concern is that oxygenation in the surrounding tissues, such as muscle
and subcutaneous tissue, is measured instead of oxygenation in the
spinal cord. Although the spatial resolution reduces the influence of
outer layers, not all extraspinal structures may have been excluded.
Nevertheless, NIRS data on regional oxygenation may adequately
reflect spinal cord perfusion, albeit indirectly, as a collateral network
ensures the shared blood supply between the spinal cord and the
surrounding tissues [10]. In order to prove this concept, LeMaire et
al. [5] injected indocyanine green dye into the subarachnoid space
and found an immediate change in light absorption, suggesting that
at least some of the photons were reaching the spinal cord.
In our case, 2 observations support the viewpoint that saturation
at the spinal cord level measured by NIRS (directly or indirectly)
reflects spinal cord perfusion. First, SsO2 at T10, which was ini-
tially pressure independent, became strongly influenced by arterial
blood pressure after endograft deployment. This is consistent with
published reports that have described the treatment of spinal cord
ischemia after endovasculair repair by increasing the arterial pres-
sure [2,11]. In addition, spinal cord perfusion became less pressure
dependent in the days following the first operation, which Etz et
al. [12] also observed in their study. Spinal cord perfusion pressure
spontaneously returned to baseline values after ∼ 48 hours.
Second, after deployment of stent-grafts from the diaphragm to
the level of the bifurcated graft perfusing the visceral arteries, NIRS
values at T10 were significantly decreased by changes in arterial
blood pressure, whereas at the L2 level, SsO2 remained stable (Fig.
4.5). This may be explained by the segmental nature of spinal
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perfusion and may suggest that SsO2 measurement includes the
spinal vasculature.
Somatosensory-evoked potentials (SSEPs) and motor-evoked
potentials (MEPs) monitoring are primarily used to monitor spinal
cord perfusion, although no prospective studies have proven its
efficacy to reduce spinal cord injury. Nevertheless, several reports
have demonstrated that spinal cord ischemia detected with SSEPs
and/or MEPs could be corrected with appropriate interventions
[13,14]. Still, SSEPs and MEPs monitoring is not widely used be-
cause of its limitations. NIRS could be useful as an adjunctive tool
to assess the entire spinal cord perfusion. Or, it may offer a simple
alternative for monitoring spinal cord ischemia when SSEPs and/or
MEPs are unavailable, especially in the postoperative period in which
SSEP/MEP monitoring is generally impractical or impossible.
Conclusion
To our knowledge, no one has demonstrated the dependence of
oxygen saturation at the level of the spinal cord on blood pressure
after thoracic stent-graft deployment. These preliminary data suggest
that NIRS may be employed for individualized management of
blood pressure during TAAA repair, both intra- and postopera-
tively. Further investigations are required to compare NIRS with
SSEPs and MEPs monitoring and to evaluate whether measuring
and intervening on the values obtained by NIRS make a difference in
the neurological outcome of patients who undergo repair of extensive
thoracoabdominal aneurysms.
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Chapter 5
NIRS as an estimate of
venous oxygen saturation
5.1 Background
Initially, the interest in the use of cerebral oximetry focused on the
detection of asymmetric changes, indicating a potentially catastrophic
cerebral event. In recent years, a growing understanding of the
physiological principles of NIRS led to a more complete appreciation
of its potential.
NIRS measures regional oxygen saturation in the cerebral cortex,
which is a predominantly venous bed [1,2]. Therefore, cerebral oxygen
saturation measured with NIRS primarily reflects venous oxygen
saturation. When cardiac output decreases progressively, cerebral
autoregulation and preferential distribution of cardiac output to
the brain preserves perfusion to the brain longer than perfusion
to any other organ system. Consequently, decreases in cerebral
venous oxygen saturation usually occur when global venous oxygen
saturation is also deteriorating. Not surprisingly, NIRS-measured
cerebral oxygen saturation was shown not only to correlate with
oxygen saturation in blood obtained from the internal jugular vein
105
106 CHAPTER 5. NIRS AS AN ESTIMATE OF SMVO2
[3], but also from the pulmonary artery [4] and superior caval vein
[3,4].
Even though perfusion of the brain is momentarily preserved
when cardiac output declines, the brain appears to offer a “window”
on global hemodynamics and NIRS seems to provide a non-invasive
monitoring tool to assess global tissue perfusion. This notion is
supported by the results of Murkin [5] who showed that optimizing
cerebral NIRS also enhanced global tissue oxygenation, resulting in
significantly less major (non-cerebral) organ morbidity. Recently,
NIRS has been suggested as a potentially valuable biomarker in
tracking the status of heart failure patients [6]. Heringlake et al.
demonstrated that preoperative cerebral oxygen saturation is reflec-
tive of global cardiopulmonary function, associated with short- and
long-term mortality and morbidity in cardiac surgery patients [7].
Mixed venous oxygen saturation (SmvO2) is generally accepted as
an indicator of adequacy of systemic oxygen balance, and its use for
guidance of therapy has been demonstrated to improve outcome [8].
However, its obligatory need for more invasive instrumentation pre-
cludes its use as a standard routine monitoring in perioperative care.
The availability of an easy to use, reliable, and non-invasive monitor
of global oxygen balance would benefit a much wider spectrum of
patients at risk for anesthesia and surgery.
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5.2 Objective
The aim of the study was to evaluate the feasibility of NIRS as a
non-invasive monitor of global oxygen balance, providing a reliable
estimate of systemic venous oxygen saturation.
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5.3 NIRS as an estimate of venous saturation
Relation between mixed venous oxygen saturation and cere-
bral oxygen saturation measured by absolute and rela-
tive near-infrared spectroscopy during off-pump coronary
artery bypass grafting. Moerman A, Vandenplas G, Bove´
T, Wouters P, De Hert S. Br J Anaesth 2013; 110: 258-65
Abstract
Background. We hypothesized that previously reported contradictory
results regarding the equivalence of mixed venous (SmvO2 ) and
cerebral (rScO2) oxygen saturation might be related to time delay
issues and to measurement technology. In order to explore these two
factors, we designed a prospective clinical study comparing SmvO2
with relative (INVOS) and absolute (Foresight) rScO2 measurements.
Methods. Forty-two consenting patients undergoing elective off-pump
coronary artery bypass grafting were included. Two INVOS and
two Foresight sensors continuously registered rScO2. SmvO2 was
measured continuously via a pulmonary artery catheter. Data were
assessed by within- and between-group comparisons and correlation
analysis.
Results. A similar time delay of 19 (4) and 18 (4) s was found for
SmvO2 compared with rScO2 measurements by Foresight and INVOS,
respectively, during hemodynamic changes. After adjusting for this
time delay, the correlation between SmvO2 and rScO2 increased from
r=0.25 to 0.75 (P<0.001) for Foresight, and from r=0.28 to 0.73
(P<0.001) for INVOS. Comparison of Foresight and INVOS revealed
significant differences in absolute rScO2 values (range 58–89% for
Foresight and 28–95% for INVOS). Changes in rScO2 in response to
acute hemodynamic alterations were significantly more pronounced
with INVOS compared with Foresight (P<0.001).
Conclusions. Considering the important time delay with SmvO2,
rScO2 seems to reflect more appropriately acute hemodynamic
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alterations. This might suggest its use as a valid alternative to
invasive monitoring of tissue oxygen saturation. Relative and ab-
solute rScO2 measurements demonstrated significant differences in
measured rScO2 values and in the magnitude of rScO2 changes during
hemodynamic alterations.
5.3.1 Introduction
A primary goal of hemodynamic management of patients undergoing
surgery is to provide adequate tissue oxygenation. Mixed venous
oxygen saturation (SmvO2) is generally accepted as an indicator of
adequacy of systemic oxygen balance, and its use for guidance of
therapy has been demonstrated to improve outcome [1]. Owing to its
invasiveness, this variable is not commonly incorporated into routine
anesthesia monitoring. The availability of an easy to use, reliable,
and non-invasive monitor of global oxygen balance would benefit a
much wider spectrum of patients at risk for anesthesia and surgery.
Near-infrared spectroscopy (NIRS) measures regional cerebral
oxygen saturation (rScO2) in the cerebral cortex, which is a
predominantly venous bed [2]. The findings of Murkin and colleagues
[3] suggest that cerebral oximetry might be useful as an index for
global oxygen delivery and consumption, indicating that NIRS might
offer a continuous, non-invasive alternative for SmvO2.
Previous studies found contradictory results regarding the
equivalence and interchangeability of SmvO2 and rScO2 data [4-12].
We hypothesized that this inconsistency might be related to two
factors. First, SmvO2 values were recorded intermittently, providing
only isolated epochs for comparison such that time delay issues may
not have been taken into account. Secondly, rScO2 measurements
were all performed with the INVOS cerebral oximeter (Somanetics
Corporation, Troy, MI, USA), which is approved by the Food and
Drug Administration (FDA) as a relative cerebral oximeter or a trend
monitor [K051274 FDA 510(k) premarket notification]. Hence, the
reported poor correlations might be the result of inherent limitations
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of the measurement technology.
In order to explore these two hypotheses, we designed a
prospective observational clinical study comparing continuously mea-
sured SmvO2 with both relative and absolute rScO2 measurements.
Because we wanted to evaluate both experimental questions in a wide
range of hemodynamic changes, we chose a model of off-pump coro-
nary artery bypass (OPCAB) surgery, as the course of this procedure
entails significant hemodynamic alterations during surgical exposure
and cardiac manipulation. The Foresight cerebral oximeter (CAS
Medical Systems, Branford, CT, USA) was chosen as comparative
NIRS technology, since it claims to be an absolute cerebral oximeter
(www.casmed.com), providing absolute rScO2 values [13,14].
5.3.2 Methods
This trial is registered at ClinicalTrials.gov (NCT01673841). After
Institutional Ethics Committee approval and written informed con-
sent, 42 patients undergoing elective OPCAB surgery for at least
three-vessel coronary artery disease were included. Patients with
arteriovenous shunts, intracardiac shunts, a previous history of cere-
brovascular accident, or stenosis of the internal carotid artery of
>60% were excluded.
Description of NIRS devices
The physical principles upon which NIRS is based have been
described [15]. In general terms, NIRS utilizes the absorption and
reflectance spectra of near-infrared light to quantify oxygenation of
tissues underlying the sensor. Both INVOS and Foresight use the
Modified Beer-Lambert law to measure tissue oxygen saturation, and
eliminate the contribution of extracerebral tissue by using the princi-
ple of spatial resolution (depth of photon penetration proportional to
the source-detector separation). However, some important technical
differences exist. The INVOS 5100 generates two wavelengths of light
at 730 and 810 nm from light emitting diodes, while Foresight uses
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laser-emitting diodes to generate light at four different wavelengths
(690, 778, 800 and 850 nm). The spacing of the light detectors from
the light emitter, which influences the sample volume and depth of
penetration, is at 3 and 4 cm distance for INVOS 5100, and at 1.5
and 5 cm for Foresight. There is also a difference in assumed cerebral
arterial:venous ratio upon which the oximetry values are calculated
(assumed ratio of 25:75 for INVOS and 30:70 for Foresight). Owing to
the technical differences and the different computational algorithms
for the calculation of tissue saturation, the comparability between
INVOS 5100 and Foresight is not clear.
Study design
On the morning of surgery, subjects were allowed to take their
routine medication, except for angiotensin-converting enzyme in-
hibitors. Four disposable oxygenation sensors [two INVOS sensors
(INVOS 5100, Somanetics Corporation) and two Foresight sensors
(CAS Medical Systems)] were applied bilaterally on the forehead for
continuous registration of rScO2. The sensors of one monitor were
placed just above the eyebrows, and the sensors of the other monitor
were placed just above the former sensors. Sensor placement was de-
termined at random by a computerized randomization list. Baseline
values were obtained at least 1 minute after placement of sensors
until values were stabilized. Anesthesia was induced with diazepam
0.1 mg/kg, fentanyl 5 µg/kg, propofol 1 mg/kg, and rocuronium 1
mg/kg. The lungs were ventilated mechanically with oxygen enriched
air (fractional inspired oxygen 0.6) adjusted to keep the end-tidal
carbon dioxide (EtCO2) around 4.7 kPa. Anesthesia was maintained
with boluses of fentanyl up to a total dose of 25-35 µg/kg and sevoflu-
rane at a minimum concentration of 1.5 vol%. Standard monitoring
was used throughout the procedure, including ECG, pulse oxime-
try, capnography, invasive arterial, central venous and pulmonary
artery pressure monitoring, continuous SmvO2 monitoring [Swan-
Ganz CCOmbo pulmonary artery catheter (Edwards lifesciences,
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Irvine, CA, USA)], and transoesophageal echocardiography.
Hemodynamic management was at the discretion of the at-
tending anesthetist. All variables were recorded continuously with
RUGLOOP (Demed, Temse, Belgium) and were analysed at two
seconds intervals. Types and volumes of all fluids were recorded, as
well as doses of any drugs given.
To explore interference when Foresight and INVOS were operat-
ing simultaneously, we included a methodological evaluation of the
reliability of our data. During preparation of the internal thoracic
artery - which includes a hemodynamic stable period - the monitors
were switched off one at a time for 5 min. During these periods,
the mean rScO2 and standard deviation (SD) were measured for
each monitor separately and compared with mean (SD) obtained
during the 5 min preceding this intervention when both monitors
were operating simultaneously.
The response of rScO2 to major hemodynamic disturbances was
explored during placement of deep pericardial stitches. During
every heart retraction, which induced a substantial decrease in mean
arterial pressure (MAP), relative changes in MAP, rScO2 and SmvO2
were calculated at 5 (T1) and 10 s (T2) after start of heart retraction,
at the minimum value of MAP (T3), and at 5 (T4), 10 (T5), 15 (T6)
and 20 (T7) s after release of heart retraction. Relative change was
defined as the percentage difference between the value just before
heart retraction and the value at the different time moments. The
integrated value or area under the curve (AUC) for rScO2 during
placement of the pericardial stitches was also explored to evaluate
the response of rScO2 to major hemodynamic disturbances . The
AUC was calculated by taking the difference between the current
values and the value just before heart retraction, multiplied by the
corresponding time in seconds, and is expressed in %.sec.
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Statistical analysis
Sample size calculation was based on an aimed correlation
coefficient of 0.5 between SmvO2 and rScO2 values [5,6]. Accepting
a two-tailed α error of 0.01 and a β error of 0.8, 42 subjects were
required. Statistical analysis was performed using SPSS Statistics
20 (SPSS Inc., Chicago, IL, USA). Distribution of data was tested
for normality using the Shapiro-Wilk test. Normally distributed
continuous data are presented as mean (SD). Non-parametric data
are presented as median [range]. Comparison of data between Fore-
sight and INVOS were performed by the Mann-Whitney U analysis.
Correlation analysis was performed by the Pearson or Spearman’s ρ
testing as appropriate. P-values <0.05 were considered significant.
5.3.3 Results
Thirty male and 12 female subjects with an average age of 72 (8) yr,
weight of 78 (16) kg, and height of 166 (8) cm were included. Awake
rScO2 values were 70 (4)% and 69 (3)% for Foresight on the left and
right side, respectively, and 64 (10)% and 64 (9)% for INVOS on
the left and right side, respectively (P<0.001 between Foresight and
INVOS). For further analysis, right and left cerebral saturations of
the corresponding monitoring system were averaged.
Mutual interference of monitors
With both monitors running simultaneously, Foresight exhibited
more variability in rScO2 than when INVOS was switched off (0.9
(0.4)% compared with 0.5 (0.2)%, P=0.004) (Fig. 5.1). INVOS
performance was not affected by the presence of Foresight (0.6 (0.2)%
vs 0.7 (0.2)% Foresight on-off, respectively, n.s.). Simultaneous
operation did not affect the mean rScO2 values for either monitor
(INVOS mean values 72 (9)% compared with 70 (15)% with Foresight
on and off, respectively; Foresight mean values 70 (4)% compared
with 70 (4)% with INVOS on and off, respectively).
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Figure 5.1: Representative example illustrating higher variability of Fore-
sight regional cerebral oxygen saturation (rScO2) values when Foresight
and INVOS monitors were operating simultaneously.
Hypothesis 1: time delay issues are responsible for reported poor
correlations
To explore this hypothesis, SmvO2, rScO2 and MAP were dis-
played graphically for each subject separately. Figure 5.2 illustrates a
representative case during the placement of deep pericardial stitches,
which was associated with substantial hemodynamic alterations.
MAP decreased briefly every time the heart was retracted to allow
the placement of the pericardial stitches. NIRS values followed imme-
diately, while SmvO2 values obviously lagged behind. This resulted
in a poor correlation between SmvO2 and rScO2 at the moment of
placement of the pericardial stitches: r=0.25 [0.01-0.67] for Foresight
and r=0.28 [0.10-0.63] for INVOS, with no significant difference
between monitors.
5.3. NIRS AS AN ESTIMATE OF VENOUS SATURATION 115
Figure 5.2: Representative case showing substantial changes in mean
arterial blood pressure (MAP) (red line) associated with retraction of the
heart during placement of deep pericardial stitches. Changes in MAP were
closely followed by changes in cerebral oxygen saturation measured by
Foresight (pink and yellow lines) and INVOS (light blue and violet lines),
while mixed venous oxygen saturation (SmvO2) (dark blue line) obviously
lagged behind.
The mean time delay between SmvO2 and MAP or rScO2
(calculated as the number of seconds between minimum SmvO2 and
minimum MAP or minimum rScO2) was 18 (4), 19 (4) and 18 (4)
seconds for MAP, Foresight and INVOS respectively. After adjust-
ing for this time delay, taking the nadir value for each variable,
the correlation between SmvO2 and rScO2 increased from r=0.25
to r=0.75 [0.15-0.88] (P<0.001) for Foresight, and from r=0.28 to
r=0.73 [0.30-0.87] (P<0.001) for INVOS, with no significant difference
between monitors.
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Hypothesis 2: role of the NIRS measurement technology
In order to investigate the hypothesis that the measurement tech-
nology might be responsible for the conflicting results reported in
previous studies [4-12], we determined whether the absolute (Fore-
sight) and relative (INVOS) NIRS monitors reported identical rScO2
values, and whether relationships between rScO2 and SmvO2 were
similar. We also analyzed the differences in response to important
hemodynamic disturbances.
The mean Foresight values were significantly higher (70 (4)%)
than the mean INVOS values (66 (10)%) (P<0.001). A histogram
of the distribution of all rScO2 data (9604 data pairs) is presented
in figure 5.3, indicating that INVOS measurements showed a wider
range of values [28-95%] than corresponding Foresight measurements
[58-89%]. As a consequence, the correlation between the individual
Foresight and INVOS rScO2 values was poor (r = 0.31).
Figure 5.3: Frequency distribution of the regional cerebral oxygen satura-
tion (rScO2) data measured with Foresight (left panel) and with INVOS
(right panel) (n=9604), demonstrating a wider range of absolute rScO2
values with INVOS [28-95%] than with Foresight [58-89%].
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Correlation analysis of all collected data pairs (n = 8338) revealed
a poor correlation between SmvO2 and rScO2 for both devices (r=0.37
for Foresight and r=0.39 for INVOS) (Fig. 5.4). The linear regression
was described by y = 0.22x+ 53 for Foresight, and y = 0.62x+ 20
for INVOS, indicating that for each % change in SmvO2, there is a
0.22% change in rScO2 for Foresight and a 0.62% change in rScO2 for
INVOS (P<0.001 between monitors). However, this analysis includes
an unequal number of data pairs per subject, which could potentially
result in an imbalanced statistical weight of subjects with exceedingly
good or bad correlations between SmvO2 and rScO2. Therefore, we
also calculated the correlation between SmvO2 and rScO2 for each
subject individually, resulting in a median correlation coefficient of
r=0.73 [0.05-0.92] and r=0.72 [0.12-0.92] for Foresight and INVOS,
respectively (no significant difference between monitors).
Figure 5.4: Correlation analysis of all collected data pairs (n=8338)
demonstrating a poor correlation between mixed venous oxygen saturation
(SmvO2) and regional cerebral oxygen saturation (rScO2) for Foresight
(r=0.37) (left panel) and INVOS (r=0.39) (right panel). The slope of rScO2
versus SmvO2 was significantly more positive for INVOS (P<0.001 versus
Foresight).
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Figure 5.5: Relative changes in mean arterial pressure (MAP) (red line),
mixed venous oxygen saturation (SmvO2) (dark blue line) and regional
cerebral oxygen saturation (rScO2) measured with Foresight (FS) (pink line)
and INVOS (light blue line) during placement of the pericardial stitches
(96 data sets). Changes in MAP are immediately followed by changes in
rScO2, while changes in SmvO2 lagged behind. Changes in rScO2 were
significantly more pronounced when measured with INVOS compared to
Foresight (* Significant difference between Foresight and INVOS, p<0.001).
BL: baseline, just before heart retraction, T1: 5 seconds after start of
heart retraction, T2: 10 seconds after start of heart retraction, T3: at the
minimum value of MAP, T4: at 5 seconds after release of heart retraction,
T5: at 10 seconds after release of heart retraction, T6: at 15 seconds
after release of heart retraction, T7: at 20 seconds after release of heart
retraction.
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The response of rScO2 to major hemodynamic disturbances was
explored during placement of deep pericardial stitches. There were a
total of 96 data sets corresponding to pericardial stitch placement.
Relative changes of MAP, rScO2 and SmvO2 during these events are
displayed in Figure 5.5, demonstrating significantly more pronounced
changes in rScO2 when measured with INVOS compared to Foresight
(P<0.001). The ratio of changes in rScO2 to changes in MAP was
21 (0.7)% and 11 (1.5)% for INVOS and Foresight, respectively
(P<0.001). Accordingly, AUC was also significantly greater for
rScO2 when measured with INVOS, that is, -68%.sec (range -3 to
-345%.sec) (=18% of AUC MAP) compared with -39%.sec (range -1 to
-285%.sec) (=10% of AUC MAP) for Foresight, P<0.001. Correlation
analysis between MAP and rScO2 demonstrated a median correlation
coefficient of r=0.72 [0.06-0.98] and 0.77 [0.49-0.96] for Foresight and
INVOS, respectively (P=0.39 between Foresight and INVOS) (Fig.
5.6). Despite similar correlation coefficients, linear regression analysis
demonstrated a significantly more positive slope of rScO2 vs MAP
for INVOS compared with Foresight (P=0.001 between Foresight
and INVOS).
Figure 5.6: Correlation analysis demonstrating significant correlation
between mean arterial blood pressure (MAP) and regional cerebral oxygen
saturation (rScO2) for Foresight (r=0.72) (left panel) and INVOS (r=0.77)
(right panel). The slope of rScO2 versus MAP was significantly more
positive for INVOS (P=0.001 compared to Foresight).
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5.3.4 Discussion
Our results indicate a substantial time delay between SmvO2 and
rScO2 measurements during hemodynamic alterations, which is
responsible for a poor correlation between the individual values
of these two variables. Comparison of data obtained with Foresight
and INVOS cerebral oximetry revealed a similar correlation between
SmvO2 and rScO2. However, the devices demonstrated significant
differences in measured rScO2 values and in the magnitude of rScO2
changes during hemodynamic alterations.
We also evaluated mutual interference by examining the variability
of rScO2 values when both monitors were running simultaneously
compared with the values when each monitor was working separately.
Our data demonstrated that INVOS performance was not affected by
the presence of Foresight, whereas Foresight rScO2 values exhibited
significant higher variability when INVOS was also switched on,
indicating interference of the Foresight measurements by the beam of
light coming from the INVOS device. However, because the induced
variability was very small and the mean Foresight rScO2 values did
not change when both devices were operating simultaneously, we
considered the observed interference as clinically irrelevant and our
data acquisition to be reliable to address the experimental question.
SmvO2 is often used in anesthesia and in intensive care to evaluate
the balance between tissue oxygen delivery and oxygen consump-
tion. However, its obligatory need for more invasive instrumentation
precludes its use as a standard routine measurement. Since it can
be expected that measurements of brain and systemic tissue oxygen
balances vary in a similar direction, the measurement of rScO2 by
NIRS could offer a promising non-invasive alternative [3]. Several
authors have compared rScO2 and SmvO2 by focusing on interchange-
ability, using SmvO2 as the standard reference [4-10]. However, rScO2
and SmvO2 measure different entities, and we should not expect that
both methods are interchangeable. While rScO2 reflects oxygen
saturation in a small region of the frontal cortex, SmvO2 repre-
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sents a measure of venous blood oxygen saturation from all organs.
This notion is supported by the observation that SmvO2 primarily
represents oxygen status in the lower body and poorly reflects brain
oxygenation [16]. Therefore, in the present study, we did not focus on
interchangeability, but on the ability of SmvO2 and rScO2 to reflect
hemodynamic changes in a similar way.
In accordance with our data, Paarmann and colleagues [4] also
demonstrated poor correlation between SmvO2 and rScO2 during
periods of hemodynamic instability compared to hemodynamic stable
periods. They attributed this finding to retention of CO2, leading
to an increase in rScO2, without a concomitant change in SmvO2.
The importance of CO2 in the correlation analysis of SmvO2 and
rScO2 has been demonstrated during moderate hypothermic car-
diopulmonary bypass [5]. The present study design does not allow
to comment on potential influences of CO2 on SmvO2 and rScO2.
Throughout the study, EtCO2 was maintained at 4.7 kPa and one can
assume that the hemodynamic disturbances occurring were too short-
lasting to result in effective alterations in arterial CO2 concentrations.
We hypothesized that time delay issues might contribute to the
poor correlation between SmvO2 and rScO2. We demonstrated a
substantial time delay between changes in MAP and concomitant
changes in SmvO2 of 18 (4) seconds, while no time delay was observed
between changes in MAP and changes in rScO2. After adjusting
for the time delay, the correlation between SmvO2 and rScO2 in-
creased significantly for both Foresight and INVOS, confirming our
hypothesis.
Most monitors use a time-weighted average to compute the value
displayed, and each device updates and displays the value at a
different rate, which might confound time delay analyses. In the
present study, MAP was displayed beat-to-beat, Foresight and SmvO2
both had a data update rate of 2 s, while the INVOS monitor had the
slowest data update rate (3.3 s). Therefore, the time delay observed
with SmvO2 compared with MAP and rScO2 cannot be attributed
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to inherent device-related time delays. We speculate that the 18 s
delay in SmvO2 compared with rScO2 reflects the circulation time.
rScO2 directly measures regional oxygen balance, whereas SmvO2 is
a reflection of the global oxygen balance, from venous blood returning
from the superior and inferior cavae and from the coronary sinus,
and is therefore subject to time delay due to the circulation time.
Of interest, the time delay between SmvO2 and rScO2 found in our
study perfectly accords with previously described circulation times
[17]. Our data imply that rScO2 might represent a prompter more
reliable variable than SmvO2 to assess the effect of changes in MAP on
tissue perfusion, because it can be assumed that when hemodynamic
deterioration leads to impaired brain perfusion, other vital organs
will also be compromized [18].
The range of rScO2 values is significant larger when measured
with INVOS compared with Foresight. This can be related to the use
of four narrow laser wavelengths (bandwidth <1 nm) in the Foresight
technology compared with the use of two broader wavelengths (band-
width 30-40 nm) in the INVOS technology (www.perfusion.com/cgi-
bin/absolutenm/articlefiles/chen2008/chen2008.pdf), improving mea-
surement accuracy [19]. However, the differences in absolute values
might also be due to different computational algorithms for the
calculation of rScO2 of both NIRS devices. Similarly, penetration
depth could differ depending on the wavelength and intensity of the
emitted light, the sensitivity of the light detector, and the spacing
between the light emitter and light detectors. Variable sensitivity
to extracranial tissue contamination is another possibility for the
observed differences [20].
We demonstrated an identical correlation between rScO2 and
both SmvO2 and MAP for the two NIRS devices. However, despite
similar correlation coefficients, the slopes of rScO2 vs SmvO2 or
MAP were significantly more positive for INVOS, suggesting a better
reflection of SmvO2 and MAP changes. Likewise the response of
rScO2 to acute hemodynamic alterations was more pronounced when
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measured with INVOS.
The underlying reasons for the differences between INVOS and
Foresight measurements cannot be identified from the present study.
Either INVOS data show a greater variability due to less accurate
measurement technology, or alternatively, Foresight data show less
variability because of a more pronounced signal attenuation tech-
nology, providing rScO2 values that do not as readily reflect true
physiological changes. Clearly, more studies are needed to clarify
this issue.
In summary, our data suggest that the conflicting and poor results
described previously when comparing rScO2 with SmvO2 can to some
extent be attributed to a time delay between measurements. rScO2
might represent a prompter more reliable variable than SmvO2 to
assess the effect of changes in MAP on tissue perfusion. We could
not confirm that the type of cerebral oximeter also contributed to the
poor correlation as previously reported. Both technologies responded
similar to hemodynamic changes, although responses of rScO2 to
changes in MAP seemed to be more pronounced when measured with
INVOS compared to Foresight.
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Chapter 6
NIRS to assess the
physiological
determinants of tissue
oxygen saturation
6.1 Background
Vasopressors are frequently used during anesthesia when blood
pressure is challenged. However, vasoconstrictors may impair regional
organ perfusion, which will go unnoticed when relying solely on blood
pressure, until functional organ damage becomes evident. Both
pressure and flow are considered important variables for prevention
of perfusion deficit and the resulting end organ failure. However, the
relative importance of each is less established.
Since NIRS provides an estimation of systemic venous saturation,
its use offers the opportunity to evaluate physiological determinants
of global tissue perfusion.
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6.2 Objective
The aim of the present study was to determine the effect of flow and
pressure on tissue oxygen saturation.
6.3 NIRS to assess physiology of perfusion
Influence of variations in systemic blood flow and
pressure on cerebral and systemic oxygen saturation in
cardiopulmonary bypass patients. Moerman A, Denys W,
De Somer F, Wouters P, De Hert S. Br J Anaesth 2013, in
press
Abstract
Background. Although both pressure and flow are considered
important determinants of regional organ perfusion, the relative
importance of each is less established. The aim of the present study
was to evaluate the impact of variations in flow and/or pressure on
cerebral and whole-body oxygen saturation.
Methods. Thirty-four consenting patients undergoing elective
cardiac surgery on cardiopulmonary bypass were included. Using
a randomized cross-over design, four different hemodynamic states
were simulated: 1) 20% flow decrease, 2) 20% flow decrease with
phenylephrine to restore baseline pressure, 3) 20% pressure decrease
with sodium nitroprusside (SNP) under baseline flow, and 4) in-
creased flow with baseline pressure. The effect of these changes was
evaluated on cerebral (ScO2) and systemic (SvO2) oxygen saturation,
and on systemic oxygen extraction ratio (OER). Data were assessed
by within- and between-group comparisons.
Results. Decrease in flow was associated with a decrease in ScO2
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(from 63.5 (7.4) to 62.0 (8.5)%, P<0.001). When blood pressure was
restored with phenylephrine during low flow, ScO2 further decreased
from 61.0 (9.7) to 59.2 (10.2)%, P<0.001. Increase in flow was associ-
ated with an increase in ScO2 from 62.6 (7.7) to 63.6 (8.9)%, P=0.03,
while decreases in pressure with the use of SNP did not affect ScO2.
SvO2 was significantly lower (P<0.001) and OER was significantly
higher (P<0.001) in the low flow arms.
Conclusions. In the present elective cardiac surgery population, ScO2
and SvO2 were significantly lower with lower flow, regardless of sys-
temic blood pressure. Moreover, phenylephrine administration was
associated with a reduced cerebral and systemic oxygen saturation.
6.3.1 Introduction
Decreases in blood pressure during anesthesia are often managed
by vasopressor use. However, vasoconstrictors may impair regional
organ perfusion, which might go undetected when monitoring solely
blood pressure [1]. Cerebral oximetry, a noninvasive technology
using near infrared spectroscopy (NIRS), enables an estimation of
systemic venous saturation, thereby providing a means for real-time
monitoring of adequacy of organ perfusion [2,3].
In a proposed algorithm to correct for decreases in NIRS-derived
cerebral oxygen saturation (ScO2), increasing mean arterial pressure
(MAP) with the use of vasopressors was suggested as one of the initial
measures to correct for low ScO2 [4]. However, recent published data
demonstrated that vasopressors such as phenylephrine may negatively
affect ScO2 [5-9]. This negative effect on ScO2 was not observed when
increase in blood pressure was obtained by vasopressor agents which
also increase cardiac output, such as ephedrine [6,10]. Also, studies
in healthy subjects demonstrated an increase in ScO2 during exercise
[7,11], whereas in patients not capable of increasing cardiac output,
such as in patients with heart failure, the ability to augment ScO2
during exercise was limited [12]. These data suggest that cardiac
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output might contribute to the preservation of cerebral oxygenation.
The aim of the present study was to determine the impact of
variations in flow, in pressure, and in both variables at the same time
on cerebral and whole-body oxygen saturation. We hypothesized
that not only pressure, but also flow would have a major contribution
in preservation of cerebral and systemic oxygenation.
A major problem in evaluating physiologic processes is that
pressure and flow are intertwined and modifications to one also
alter the other. Cardiopulmonary bypass (CPB) represents a unique
clinical circumstance in which different aspects of perfusion can be
modified independently and in a controlled manner. Therefore we
chose CPB as the model to test our hypothesis. To separate the
effect of flow and pressure on cerebral and systemic oxygenation, we
independently modified these parameters in patients on CPB.
6.3.2 Methods
This prospective clinical study was approved by the Institutional
Ethics Committee and written informed consent was obtained from all
subjects. The trial is registered at ClinicalTrials.gov (NCT01424800).
Thirty-four adult patients scheduled for elective cardiac surgery
(coronary artery bypass grafting and/or valve surgery) on moderately
hypothermic CPB without blood transfusion were recruited. Patients
with history of cerebrovascular disease or significant carotid artery
stenosis (>60%) and patients necessitating vasopressor or inotropic
therapy before surgery were excluded.
On the morning of surgery, patients were allowed to take their
routine medication, except for angiotensin-converting enzyme in-
hibitors. Patients were premedicated with oral diazepam (5-10 mg).
Standard monitoring was used throughout the procedure, including
ECG, pulse oximetry, end-tidal oxygen, carbon dioxide and sevoflu-
rane concentrations, bispectral index (BIS), invasive arterial and
central venous pressure measurement, and temperature measure-
ment (AS3; Datex, Helsinki, Finland). Arterial blood pressure was
6.3. NIRS TO ASSESS PHYSIOLOGY OF PERFUSION 131
recorded continuously via the right radial artery catheter. Two
disposable NIRS sensors were applied on each side of the forehead
for continuous registration of ScO2 of the corresponding brain hemi-
sphere (INVOS 5100; Somanetics Corporation, Troy, MI, USA). All
data were recorded continuously and integrated digitally with the
RUGLOOP (Demed, Temse, Belgium).
Anesthesia was induced with fentanyl 5 µg/kg, diazepam 0.1
mg/kg, and rocuronium 1 mg/kg. The lungs were ventilated me-
chanically with oxygen-enriched air (fractional inspired oxygen 0.6)
adjusted to keep the end-tidal carbon dioxide (EtCO2) around 5 kPa.
Anesthesia was maintained with boluses of fentanyl up to a total
dose of 25-35 µg/kg and sevoflurane at a minimum concentration of
1.5 vol%.
CPB was performed with a roller pump (Sto¨ckert S5; Sorin
group, Mu¨nchen, Germany) providing non-pulsatile flow. The
priming consisted of 1200 ml colloids (Geloplasma R©, Fresenius Kabi,
Schelle, Belgium), heparin 5000 IU and mannitol 0.5 g/kg. Sys-
temic heparinization maintained an activated clotting time of >480
seconds. Moderately hypothermic CPB (blood temperature 30 ◦C)
was initiated at flow rates of 2.5 L/min/m2. During CPB PaO2
and PaCO2 were maintained around 25 kPa and 5 kPa respectively.
Arterial blood gases were measured at 37 ◦C, independent of body
temperature (alpha-stat blood gas management). Blood was sampled
from the pump oxygenator after 3 minutes during steady state, I1
and I3. Temperature, PaCO2, PaO2, haemoglobin and sevoflurane
concentrations were kept constant during the measurements.
Interventions
The study used a randomized cross-over design where the subjects
served as their own controls. Subjects were randomly allocated, based
on computer generated codes, to start with the flow related inter-
ventions or with the pressure related interventions. In all subjects,
response to variations in flow, in pressure, and to the combined
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variation of flow and pressure was investigated. With the interven-
tions, a change of 20% in pressure and/or flow was aimed. Changes in
blood pressure were obtained by the use of vasoactive agents, sodium
nitroprusside (SNP) for blood pressure decrease and phenylephrine
for blood pressure increase. Flow was regulated by control of the
pump flow.
Baseline (BL) values of mean arterial blood pressure (MAP), flow,
ScO2 and systemic oxygen saturation (SvO2) were determined at
steady state. Steady state was defined as the presence of a stable
(<10% change) MAP over a period of 5 minutes on CPB. After reach-
ing steady state, four different hemodynamic states were simulated:
20% flow decrease (I1), 20% flow decrease with administration of
phenylephrine to restore baseline MAP (I2); then hemodynamics
were allowed to return to BL values after which SNP was admin-
istered until 20% MAP decrease under baseline flow (I3), followed
by restoration of baseline MAP by increasing pump flow (I4). The
order of variations in pressure and flow was assigned randomly by
the use of a computer generated randomization code. Subjects were
randomly assigned to undergo first the flow related interventions and
then the pressure related interventions (group F), or first the pressure
related interventions and then the flow related interventions (group
P). All changes were sustained for 5 minutes. In group F the sequence
of changes was BL, I1, I2, BL, I3, I4. In group P the sequence of
changes was BL, I3, I4, BL, I1, I2 (Fig. 6.1). Interventions were
separated by a time period of about 2 minutes for finalizing computer
data registration and preparation of the next intervention.
Outcome variables
To analyze the changes in ScO2, right and left ScO2 were averaged.
We calculated both the change in absolute values in ScO2, as the
relative change in ScO2, defined as the percentage difference between
the ScO2 value at the start of the intervention and the value exactly
5 minutes later, at the end of the intervention. To account for both
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Figure 6.1: Graphic presentation of the study design. Sequence of inter-
ventions in group F (first the flow related interventions) and group P (first
the pressure related interventions).
magnitude and duration of changes in ScO2, the area under the curve
(AUC) was also calculated (expressed in %.sec).
To evaluate the effect of changes in flow and pressure on whole-
body oxygen balance, SvO2 was measured, and systemic oxygen
delivery (DO2) and oxygen extraction ratio (OER) were calculated
according to standard formulae. Arterial oxygen content: CaO2 =
1.34∗Hb∗SaO2+0.003∗PaO2, where Hb = hemoglobin concentration,
SaO2 = arterial oxygen saturation, PaO2 = arterial partial pressure
of oxygen. DO2 = Q ∗ CaO2, where Q = pump flow. OER =
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(SaO2 − SvO2)/SaO2, where SvO2 = venous oxygen saturation.
Statistical analysis
Lucas and co-workers assessed the influence of pharmacological-
induced changes in blood pressure on cerebral oxygenation, and
indicated an absolute change in ScO2 of -1.8% per 10 mmHg change
in MAP, with a reduction approximating 14% during the higher
range of MAP [8]. In the present protocol we aimed at a change of
20% in pressure with the interventions. We therefore accepted an
absolute change in rScO2 of 5% with alterations in pressure or flow
as a clinically relevant change. Based on the reported mean ScO2
of 64% with a SD of 10% [3], and accepting a two-tailed α error of
0.05 and a β error of 0.8, 34 patients were calculated to be required.
Statistical analysis was performed using the statistical software SPSS
Statistics 20 (SPSS Inc., Chicago, IL, USA). Distribution of the
data was tested for normality using the Shapiro-Wilk test. The
assumption of normality was fulfilled and data are presented as mean
(SD). Comparisons between group F and group P were made with
Student’s t-test. Variables during the different interventions were
compared using repeated measures analysis of variance (ANOVA),
with Tukey correction for multiple post-hoc comparisons. For each
intervention, differences between pre- and post-intervention ScO2
values were tested using a paired data Student’s t-test. A value of
P<0.05 was taken as the level of significance.
6.3.3 Results
Nine female and 25 male subjects with an average age of 62 (14)
years, weight of 80 (16) kg and height of 171 (9) cm were enrolled
in the study. Demographics did not differ between the F and the P
group.
Temperature, sevoflurane concentrations, PaO2, PaCO2 and
hemoglobin showed no differences between the different interventions,
neither between the F and the P group (Table 6.1).
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BL I1 I2 I3 I4
Temp (◦C)
F group 30.5 (1.3) 30.7 (1.4) 31.0 (1.1) 30.7 (1.3) 30.7 (1.3)
P group 30.0 (1.5) 30.1 (1.2) 30.2 (1.6) 30.3 (1.4) 30.5 (1.4)
Sevo (%)
F group 1.1 (0.5) 1.2 (0.5) 1.2 (0.5) 1.2 (0.5) 1.3 (0.5)
P group 1.0 (0.3) 1.4 (0.7) 1.3 (0.7) 1.1 (0.4) 1.1 (0.4)
PaO2 (kPa)
F group 33 (9) 30 (5) 30 (6)
P group 30 (7) 28 (7) 27 (7)
PaCO2 (kPa)
F group 5.8 (0.5) 5.5 (0.6) 5.7 (0.2)
P group 5.6 (0.6) 5.0 (0.4) 5.0 (0.5)
Hb (g/dl)
F group 9.8 (0.9) 9.9 (1.1) 10.1 (0.9)
P group 9.5 (1.4) 10.0 (1.2) 9.5 (1.3)
Table 6.1: Blood temperature, sevoflurane concentration, and blood gas values
during the different interventions, demonstrating no differences between the interven-
tions, neither between the F group (flow related interventions were performed before
the pressure related interventions) and the P group (pressure related interventions were
performed before the flow related interventions). Data are presented as mean (SD). P-
value between F and P group >0.05; P-value between interventions >0.05. BL: baseline,
(I1) 20% flow decrease, (I2) 20% flow decrease with administration of phenylephrine to
restore baseline MAP, (I3) baseline flow with administration of sodium nitroprusside un-
til 20% MAP decrease, (I4) restoration of baseline MAP by increasing pump flow; PaO2:
arterial oxygen partial pressure, PaCO2: arterial carbon dioxide partial pressure, Hb:
hemoglobin.
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The intended targets of changes in flow and MAP were reached
in all subjects (Table 6.2). The changes in flow and MAP were not
different between the F and the P group, indicating that the sequence
of interventions did not bias the data. Therefore, in order to analyze
the effect of changes in flow and pressure, we pooled the data of both
groups.
BL I1 I2 I3 I4
Flow (L/min)
F group 4.5 (0.5) 3.6 (0.4) 3.6 (0.4) 4.5 (0.5) 5.0 (0.5)
P group 4.4 (0.4) 3.6 (0.3) 3.6 (0.3) 4.4 (0.4) 4.9 (0.5)
MAP (mmHg)
F group 67 (5) 57 (8) 69 (8) 57 (7) 65 (8)
P group 70 (9) 63 (9) 71 (9) 57 (7) 68 (8)
Table 6.2: Endpoints of changes in flow and pressure during the different interven-
tions, indicating that the intended targets of changes in flow and pressure were reached
in all subjects. Data are presented as mean (SD). P-value between F and P group
>0.05; P-value between interventions <0.001. BL: baseline, (I1) 20% flow decrease, (I2)
20% flow decrease with administration of phenylephrine to restore baseline MAP, (I3)
baseline flow with administration of sodium nitroprusside until 20% MAP decrease, (I4)
restoration of baseline MAP by increasing pump flow.
DO2 was significantly lower during low flow (I1) (263 (62)
ml/min/m2) compared to normal flow (I3) (320 (63) ml/min/m2),
P=0.001.
The changes in MAP and flow with their concomitant effects on
ScO2 are illustrated in Figure 6.2. The changes in ScO2 and systemic
oxygen balance parameters between the interventions are displayed
in Table 6.3.
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Figure 6.2: Changes in MAP and flow with their concomitant effects
on ScO2 for each intervention: (I1) 20% flow decrease, (I2) 20% flow
decrease with administration of phenylephrine to restore baseline MAP, (I3)
baseline flow with administration of sodium nitroprusside until 20% MAP
decrease, (I4) restoration of baseline MAP by increasing pump flow. Data
are presented as mean values. *p<0.05 between pre- and postintervention
ScO2.
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BL I1 I2 I3 I4
AUC rScO2 N.A. -522(323)* -249(424)* 145(687) 232(379)
(%.sec)
Rel. change N.A. -2.8(3.7)* -3.2(3.8)* 1.5(5.1) 1.6(3.3)
in rScO2 (%)
SvO2 (%) 86(3) 82(4)‡ 82(5)‡ 85(4) 87(4)
OER 0.14(0.03) 0.18(0.04)‡ 0.17(0.05)‡ 0.14(0.04) 0.12(0.04)
Table 6.3: Cerebral oxygen saturation and oxygen consumption parameters during
the different interventions, demonstrating lower cerebral (ScO2) and systemic (SvO2)
oxygen saturation and a higher oxygen extraction ratio (OER) during low flow (I1 and
I2) compared to baseline (BL), normal flow (I3), and high flow (I4). Data are presented
as mean (SD). *Significantly different from I3 and I4; ‡ Significantly different from
BL, I3 and I4. (I1) 20% flow decrease, (I2) 20% flow decrease with administration of
phenylephrine to restore baseline MAP, (I3) baseline flow with administration of sodium
nitroprusside until 20% MAP decrease, (I4) restoration of baseline MAP by increasing
pump flow. AUC ScO2: area under the curve for cerebral oxygen saturation, N.A.: not
applicable.
Responses to decrease in flow
Intervention 1 : With 20% flow decrease, MAP decreased from 65
(9) to 60 (11), indicating the accompanying decrease in MAP with
flow decrease. ScO2 decreased from 63.5 (7.4) to 62.0 (8.5)%, P<0.001
(Fig. 6.2). Decreases in ScO2 were significantly more pronounced
compared to interventions with normal (I3) and high flow (I4) (Table
6.3). SvO2 was significantly lower and OER was significantly higher
compared to baseline and compared to interventions with normal
and high flow (Table 6.3).
Intervention 2 : With 20% flow decrease and administration of
phenylephrine to restore baseline MAP, MAP increased from 57 (10)
to 70 (8). ScO2 decreased from 61.0 (9.7) to 59.2 (10.2)%, P<0.001
(Fig. 6.2). Decreases in ScO2 were significantly more pronounced
compared to interventions with normal (I3) and high flow (I4) (Table
6.3). SvO2 was significantly lower and OER was significantly higher
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compared to baseline and compared to interventions with normal
and high flow (Table 6.3).
Responses to decrease in pressure
Intervention 3 : With 20% MAP decrease (from 66 (12) to 57 (7)),
obtained by administration of SNP while maintaining baseline pump
flow, ScO2 did not change significantly (61.7 (8.4) to 62.6 (8.4)%,
P=0.13) (Fig. 6.2). SvO2 was significantly higher and OER was
significantly lower in conditions with low blood pressure obtained by
SNP (I3) compared to low blood pressure caused by low flow (I1)
(Table 6.3).
Responses to increase in flow
Intervention 4 : When increasing pump flow until restoration of
baseline MAP (from 61 (11) to 67 (8)), the increase in flow was
11% (from 4.5 (0.5) to 5.0 (0.5) L/min). ScO2 increased from 62.6
(7.7) to 63.6 (8.9)%, P=0.03) (Fig. 6.2). ScO2 values were not
different between conditions with high flow and baseline pressure
(I4) compared to baseline flow and low pressure by SNP (I3) (Table
6.3). SvO2 was significantly higher and OER was significantly lower
compared to conditions with low flow (I1 and I2) (Table 6.3).
6.3.4 Discussion
The debate on the best strategies for prevention of perfusion deficit
and the resulting end organ failure is ongoing. Both pressure and
flow are considered important variables [13]. However, the relative
importance of each is less established. Under the conditions of the
present study, changes in flow affected cerebral and systemic venous
oxygen saturations more than changes in MAP. ScO2 and SvO2 were
significantly higher at normal to high flow than at reduced flow,
regardless of systemic blood pressure.
In the elective cardiac surgery population, used in this study,
maintaining flow and thus DO2 seemed to be more important than
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maintaining pressure. This finding is in accordance with data demon-
strating that organ injury can be prevented by targeting DO2 levels
above a critical threshold during cardiopulmonary bypass [14,15].
However, the obtained results do not exclude perfusion pressure as
an important variable. It is important to note that even during low
pressure, our lowest value of 60 mmHg is higher than the critical
value of 50 mmHg as reported in other studies [16].
In the present study increasing blood pressure with phenylephrine
induced a decrease in ScO2. This is in accordance with a number of
recently published studies [5-9]. The mechanism of this phenomenon
is still unknown. Cardiac output has been proposed as the most
important factor in preserving ScO2 [5]. However in our study, pump
flow was kept constant during administration of phenylephrine, indi-
cating that other factors than cardiac output or pump flow contribute
to the decrease in ScO2. Some authors relate the decrease in ScO2
with phenylephrine to direct α-1 adrenergic receptor activation [17]
or to indirect cerebral vasoconstriction via reflexively increased sym-
pathetic nerve activity [18]. Others refute this mechanism by stating
that the cerebral vasculature lacks significant α- and β-adrenoceptors
[19]. Recently it has been suggested that the ScO2 decrease with
administration of phenylephrine indicates a functional pressure au-
toregulation mechanism [20]. The phenylephrine-induced increase in
perfusion pressure provokes vasoconstriction of the cerebral arterioles
in order to prevent abrupt cerebral hyperperfusion. NIRS calculates
the oximetry values based on an assumed cerebral arterial to venous
blood volume ratio [21]. Autoregulatory vasoconstriction of the cere-
bral arterioles induces a smaller arterial and relatively larger venous
contribution to the NIRS signal, causing a decrease in ScO2. This
hypothesis is supported by the study of Ogoh and colleagues who
evaluated arterial and venous cerebral blood flow, and demonstrated
an elevated arterial tone and reduced cerebral venous tone during
phenylephrine administration, indicating cerebral autoregulation [9].
The ScO2 increase with SNP-induced hypotension could be readily
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explained by the same mechanisms. Either nitrates reduce the
resistance in the cerebral vessels, allowing more blood flow to the
brain [22], or the ScO2 increase with administration of SNP could
be considered as a functional pressure autoregulation mechanism,
provoking vasodilation of the cerebral arterioles in order to prevent
cerebral hypoperfusion.
It might be argued that the cerebral autoregulation-induced
altered A:V ratio accounts for the observed changes in ScO2, without
a genuine change in cerebral oxygenation. However, the consistent
and concordant changes in both ScO2 and systemic oxygen balance
parameters during the different interventions, suggest that ScO2
changes actually reflect oxygen balance changes.
The magnitude of changes in ScO2 in this study was very small
(∼ 0.9-1.8% absolute change depending on the intervention) and
although statistically significant, the clinical relevance of these
changes in the present study may be debatable. However, our results
cannot be implicitly extrapolated to any other clinical situation. First,
our measurements were done during moderate hypothermia which
reduces oxygen consumption, with consequently smaller changes in
ScO2. Second, we used sevoflurane for maintenance of anesthesia,
which might have blunted the decrease in ScO2 with administration
of phenylephrine by its cerebral vasodilatory effect [23,24]. Based on
the same mechanism, the decrease in ScO2 with phenylephrine will
be intensified in case of hypocapnia [20]. Third, flow and pressure
were manipulated within physiological ranges for short periods of
time. In clinical practice larger changes for a longer period are often
- deliberately or not - the case.
The results of the present study should be interpreted within the
constraints of the methodology. First, to explore the relative contri-
bution of flow and pressure on cerebral oxygenation, and with the
aim to separate the effects of both parameters, the present study was
performed in patients on CPB where both the flow and the pressure
component of perfusion can be modified in a controlled manner.
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However, as was to be expected, changes in flow were accompanied
by changes in pressure (I1 and I4) (Fig. 6.2). Secondly, based on
the principle of spatially resolved spectroscopy, NIRS devices should
theoretically distinguish between absorption of photons returning
from deep rather than from superficial tissue. However, recently 2
reports demonstrated that extracranial contamination significantly
influences the NIRS signal [25,26]. Because both vasodilators and
vasoconstrictors might affect skin flow directly, changes in skin blood
flow might have influenced the NIRS measurements of cerebral oxy-
genation. It has been suggested that the cerebral oximeter used
in the present study is more prone to extracranial contamination
[25]. Therefore, administration of vasoactive medication might result
in more pronounced artifactual measurements compared to cere-
bral oximeters with less extracranial contribution. Interestingly,
we recently demonstrated that ScO2 responses to acute haemody-
namic alterations were also more pronounced when measured with
INVOS [3]. It is unclear whether this has to be explained by a less
accurate measurement technology of INVOS, or whether the other
cerebral oximetry devices use a more pronounced signal attenua-
tion technology, resulting in more stable -but less representative-
values for both intra- and extracranial measurements. Third, NIRS
measures oxygen saturation in a superficial area of the brain directly
below the sensors, but does not examine the deep brain. As recently
demonstrated, though a low NIRS value predicts brain hypoperfu-
sion, a normal NIRS value may not always imply that perfusion is
adequate [27]. Therefore, the utility of NIRS for individualization of
perioperative pressure and blood flow management awaits testing in
properly designed and executed clinical trials [28].
In conclusion, in the elective cardiac surgery population used in
this study, cerebral saturation seemed to be more dependent on flow
than on pressure maintenance. Moreover, blood pressure increase
with phenylephrine elicited reduced cerebral and systemic oxygen
saturation.
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Chapter 7
General discussion
The treatment objective for any anesthetist is to provide the best
and most safe treatment with the best possible outcome. Over
the last 25-50 years the incidence of death directly attributable
to anesthesia has fallen from 1 in 2500 in the mid-1950s to 1 in
200 000 nowadays [1]. Several authors suggested that the incidence
of death and complications could be further reduced by deliber-
ately enhancing the balance between tissue oxygen delivery and
tissue oxygen consumption, thereby preventing perioperative tissue
oxygenation debt (Goal Directed Therapy) [2,3]. However, current
standard anesthesia monitoring does not give an early indication of
impending and developing tissue oxygen debt. Improving outcome
in our patients will require that anesthetists become more proactive
in their monitoring techniques.
Near-infrared spectroscopy (NIRS) is a non-invasive technology
that continuously monitors regional tissue oxygenation. Originally
used for assessment of oxygen saturation of the brain, its use has now
been expanded to evaluation of oxygenation of tissues other than the
brain. There is also growing evidence for the larger applicability of
NIRS as an estimate of systemic venous saturation in correspondence
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with the adequacy of the circulatory status. New and promising
advances may further this technology to become part of our standard
armamentarium, in order to optimize patient care in daily anesthesia
practice.
The present thesis describes and discusses the feasibility of clinical
monitoring with NIRS to counter the current shortcomings in anes-
thesia monitoring. This thesis reports the potential of NIRS to assess
the oxygen balance in patient groups vulnerable to global or regional
perfusion deficits, thereby enabling optimization of hemodynamic
management.
Chapter 1 summarizes the different technical issues of NIRS and
highlights the clinical considerations in cerebral NIRS monitoring.
Following that, it is always useful to remember that no monitoring
device - no matter how insightful its data - will improve patient
outcome unless used with a comprehensive monitoring strategy
(Fig. 7.1).
Figure 7.1
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Applicability of NIRS to assess perioperative global and
regional cerebral perfusion
Dramatic case reports of adverse neurological outcome after minor
surgery in relatively healthy patients indicate the shortcomings of
current routine anesthesia monitoring. The technical difficulties
and/or invasiveness of brain monitoring preclude its use as a standard
routine monitoring in perioperative care. As NIRS offers simple,
non-invasive, real-time monitoring of cerebral oxygen saturation, its
utility as an additional anesthesia monitoring tool deserves further
investigation. In this thesis we investigated the use of NIRS for
detection of cerebral perfusion deficit, both global and regional, and
we assessed the physiological determinants that influence cerebral
oxygen saturation.
The surgical and anesthetic communities have been recently
alarmed by a series of dramatic neurological outcomes in patients
after shoulder surgery in the upright position. Although the exact
pathogenesis of these events was unknown, malrotation of the head
and perioperative hypotension were intuitively implicated as the
causal factors. We hypothesized that cerebral hypoperfusion might
go unnoticed when relying solely on blood pressure. Therefore we
evaluated the prevalence of cerebral oxygen desaturation in 20 con-
secutive adult patients undergoing shoulder surgery in the upright
position. Routine anesthesia management and standard anesthesia
monitoring were used. The responsible anesthetist was not informed
about the purpose of the study and was blinded for the rScO2 data.
The study is presented in chapter 3.3. We observed a relative
decrease in rScO2 of more than 20% in 80% of patients when the
beach chair position was adopted, underlining the need for awareness
of this problem and indicating the need for perioperative monitoring
of cerebral oxygen saturation in this type of surgery. In the same
study, we identified blood pressure and carbon dioxide concentration
as physiological determinants for cerebral desaturation.
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In chapter 3.4, we demonstrate the utility of NIRS in the
management of a patient with moyamoya disease, which is a chronic
cerebrovascular occlusive disease, severely compromizing blood supply
to the brain. The use of real-time cerebral oxygenation monitoring
with NIRS identified a severe decrease in rScO2 with the initiation
of cardiopulmonary bypass. By the use of NIRS, which enabled close
monitoring of all therapeutic actions taken, the decrease in rScO2
could finally be reversed by initiating pulsatile bypass flow.
During repair of aortic coarctation through left thoracotomy,
cross-clamping of the left carotid artery is often indicated. This
might result in temporary hypoperfusion of the left brain. Since
it has been reported that sodium nitroprusside (a blood pressure
regulating agent) has an adverse effect on left-sided rScO2 during
aortic coarctation repair, we aimed to compare the effect of three
different blood pressure regulating agents on left-sided rScO2. This
study is presented in chapter 4.3. We observed a variable response
of the left-sided rScO2, ranging from a decrease to an increase in
rScO2, independent of the treatment group. Therefore, we conclude
that the decrease in left-sided rScO2 is not the result of an agent
specific effect, but most probably reflects a deficient circle of Willis.
In this study, we also observed impairment of cerebral autoregulation
with sodium nitroprusside and sevoflurane, whereas autoregulatory
capacity was maintained with nitroglycerin.
With the exception of the patient with moyamoya disease (chapter
3.4), who suffered from prolonged somnolence and a transient paresis
of the left arm, none of our patients developed gross neurological or
cognitive dysfunction postoperatively. In this regard, it is important
to note that it is a time-dependent exposure to a certain degree
of cerebral desaturation (a viability-time threshold) that eventually
leads to irreversible tissue damage and subsequent functional impair-
ment [4,5]. Therefore, the term ‘desaturation score’ was introduced
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[5], which represents an integrated oxygen saturation, or an area
under the curve (AUC). This value is calculated by the product of
length of time and depth of rScO2 below a specific threshold, and
is expressed in %.sec. To account for both depth and duration of
change in tissue oxygen saturation, we used the AUC value in many
of the studies presented in this thesis.
For the applicability of NIRS for assessment of perioperative
cerebral perfusion deficit, we conclude that monitoring of cerebral
oxygen saturation with NIRS allows to identify global and regional
cerebral hypoperfusion, enabling real-time assessment of the effects
of critical events and therapeutic actions. We demonstrated that
changes in cerebral oxygenation are related to blood pressure and
pulsatility, and to changes in CO2, and that cerebral autoregulation
might be impaired by the use of vasodilating drugs.
Applicability of NIRS to assess perioperative tissue
perfusion
Initial research focused on the use of NIRS as a monitor of cerebral
oxygen saturation, however interest extended soon to applications
in tissues other than the brain. For a number of applications there
is little evidence yet that the device truly interrogates the organ of
interest, nor that changes in the oxygen status of non-vital organs
have to be intervened upon. Future work is needed to identify
which applications, and which changes in oxygen status in these
applications, are of benefit in clinical practice.
In chapter 4.3, we evaluate the effect of different blood pressure
regulating agents on renal and muscle oxygen saturation in children
undergoing aortic coarctation repair. As expected, renal and muscle
oxygen saturations showed a rapid and significant drop after aortic
cross-clamping, which recovered promptly after release of the aortic
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cross-clamp. Interestingly, in this clinical study, we demonstrated
that decreases in renal and muscle oxygen saturation were larger and
had a faster rate of decay in patients treated with sodium nitroprus-
side (SNP) compared to nitroglycerin (NTG), which confirms the
results of a previous animal study. Our data suggest that NTG might
be preferable for blood pressure control during surgical procedures
involving aortic cross-clamping.
During thoracoabdominal aortic aneurysm repair, spinal cord
perfusion is severly jeopardized. Close monitoring is mandatory to
detect spinal cord ischemia in time to treat it. However, due to
technical difficulties and inherent limitations, central nervous system
monitoring is not widely used in these cases. In chapter 4.4, we
present preliminary data suggesting that NIRS monitoring at the level
of the spinal cord may identify spinal cord ischemia, and may function
as a valuable perioperative non-invasive guide to the management of
blood pressure in patients undergoing thoracoabdominal aneurysm
repair.
Investigation of the effect of aortic cross-clamping on renal, muscle,
and spinal oxygen saturation, demonstrated that NIRS provides real-
time assessment of regional tissue perfusion. Its use might optimize
perioperative blood pressure management in surgical procedures
involving aortic cross-clamping.
Applicability of NIRS to assess the physiological deter-
minants of tissue oxygen saturation
A growing understanding of the physiological principles of NIRS
led to an appreciation of its applicability as a monitor of global
oxygen balance, providing a non-invasive estimate of systemic oxygen
balance.
153
In chapter 5, we examine the equivalence and interchangeability
of mixed venous and cerebral oxygen saturation. The study
demonstrates that mixed venous oxygen saturation has a substantial
time delay between changes in blood pressure and concomitant
oxygen saturation changes, whereas cerebral oxygen saturation
reacts promptly, without time delay, indicating that cerebral oxygen
saturation might represent a prompter more reliable variable than
mixed venous oxygen saturation to assess the effects of changes in
blood pressure on tissue perfusion.
Considering the important time delay between SmvO2 and rScO2,
correlation analysis is probably not the right test to evaluate the
equivalence of these 2 parameters. Though correlation is the sim-
plest way to compute the relation between two signals, delayed
dynamics between the signals generate smaller correlation coefficients,
as demonstrated in our study. Coherence, as correlation, is a measure
of strength of a linear relation, but was developed for the analysis of
time-invariant systems [6]. In future studies comparing SmvO2 and
rScO2, this time delay has to be accounted for when choosing the
statistical method.
The data in this thesis demonstrate that tissue oxygen satura-
tion measured with NIRS provides a prompt responsive monitor of
changes in perfusion. However, in vivo changes in pressure are accom-
panied by changes in flow, and therefore it remained undetermined if
maintaining pressure and/or flow was the best strategy for prevention
of perfusion deficit and the resulting end organ failure. We therefore
explored the impact of flow and pressure on cerebral and whole body
oxygen saturation during cardiopulmonary bypass, where flow and
pressure can be modified independently and in a controlled manner
(chapter 6). In the elective cardiac surgery population used in that
study, maintaining flow seemed to be more important than maintain-
ing pressure. Moreover, increasing blood pressure with phenylephrine
elicited reduced cerebral and systemic oxygen saturation. It is im-
portant to note that, throughout all our studies, our lowest mean
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blood pressure values were consistently higher than the reported
critical value of 50 mmHg, and therefore, the obtained results do not
exclude perfusion pressure as an important variable. Nevertheless,
our results are in accordance with data demonstrating that organ
injury can be prevented by targeting oxygen delivery levels above a
critical threshold.
Nearly one century ago, Jarisch stated “It was fatal for the
development of our understanding of circulation, that blood flow
is relatively difficult to measure, whereas blood pressure is easily
measured. This is the reason why the blood pressure meter has
gained such a fascinating influence, although most organs do not
need pressure, but blood flow.” (A. Jarisch, “Kreislauffragen” 1928).
Our results fully support this statement.
Applicability of NIRS to assess cerebral autoregulation
In chapter 3.3, chapter 4.3 and chapter 6.3, NIRS monitoring
was mentioned in the context of cerebral autoregulation.
In the current standard of care, a systemic MAP of 50-60 mmHg is
widely considered to guarantee adequate cerebral perfusion, because
of cerebral autoregulation maintaining a constant cerebral blood flow
(CBF) in the face of changing cerebral perfusion pressure. However,
this practice fails to consider that cerebral autoregulation is derived
based on limited data that have been seriously questioned, has wide
interindividual variation, and may be altered in specific diseases
(e.g. hypertension, diabetes, stroke) and in specific conditions (e.g.
changes in CO2, pharmacologic interference) [7]. Studies identifying
the lower limit of cerebral autoregulation (LLA) in healthy, normoten-
sive, nonanesthetized adults demonstrated actual LLA values of 70
mmHg or higher [7]. Agents with cerebral vasodilating properties,
including anesthetic agents, lower the effective LLA [8,9]. Although
this might increase ‘CBF reserve’, it remains unreasonable to accept
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an empirically chosen LLA for every anesthetized patient in every
situation. So, if one rejects the validity of a fixed LLA to guide
clinical management, do we have any alternatives?
Recently, the use of NIRS to monitor cerebral autoregulation has
become an area of intense investigation. Cerebral autoregulation is
measured by quantifying the consequence of changing blood pressure
on CBF. It has been demonstrated in laboratory and clinical studies
that NIRS signals provide an acceptable surrogate for monitoring
changes in CBF for an index of autoregulation [10,11]. Real-time
autoregulation monitoring can be accomplished by the continuous
calculation of the correlation coefficient between MAP and rScO2,
generating a novel index of autoregulatory vasoreactivity, the cerebral
oximetry index (COx). Blood pressure in the autoregulation range is
indicated by a COx that approaches zero, while a COx approaching
1 indicates MAP below the LLA or disturbed autoregulation [12-14].
The COx has been validated and had good agreement with trans-
cranial Doppler derived measurements of pressure autoregulation in
piglets [10] and in adult patients [15-17]. However, analysis of COx
requires complex signal processing and specialized software, limiting
its applications mostly to research. Recently, an investigational pro-
totype NIRS monitor was validated for automated and continuous
monitoring of cerebral autoregulation [18]. The availability of such
a device offers the opportunity of widespread autoregulation moni-
toring, providing effective means for individualizing blood pressure
management.
In line with the previously mentioned studies, we evaluated
the concordance between MAP and rScO2 using simple correlation
analysis. However, cerebral autoregulation is a complex physiological
system, and correlation analysis does not cope with the complex
interplay and the time-varying aspects of the different physiological
mechanisms [19]. Coherence and transfer function analyses have
also been used to quantify cerebral autoregulation [20,21]. Caicedo
analyzed 4 different measurement models used for cerebral autoregu-
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lation assessment (correlation, coherence, modified coherence, and
transfer function) and proposed transfer function gain as the most
robust method when used for cerebral autoregulation studies [6].
Correlation was considered as a robust method, however with some
time delay-related restrictions.
Conclusion. NIRS: When and why should we measure?
In an era where clinical outcome is increasingly determined by
optimizing specific target organ function, there is a constant need
for accurate and specific monitoring equipment during the critical
perioperative period. Based on the direct relationship between cere-
bral oxygenation and neurological outcome, NIRS has been used
to detect deficits in cerebral perfusion during complex cardiac and
cerebrovascular procedures. NIRS also demonstrated its utility for
the detection of tissue hypoperfusion in other surgical areas, where
specific target organ oxygenation still remains poorly monitored in
clinical anesthesia. More importantly, there is growing evidence for
the larger applicability of NIRS as an estimate of systemic venous sat-
uration in correspondence with the adequacy of the circulatory status.
The information provided by this technology could significantly alter
our management of physiologic perturbations during anesthesia. Due
to the advantage of simple, continuous and non-invasive monitoring,
NIRS has the potential to become a valuable tool to optimize patient
care in our daily anesthesia practice.
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Chapter 8
Future perspectives
Near-infrared spectroscopy was introduced in our cardiac surgery
department in 2006, initially for cerebral monitoring during pediatric
cardiac surgery and aortic arch surgery. However, growing clinical
experience, together with cases where unexpected events were
detected by NIRS, soon led us to adopt NIRS as routine monitor in
every cardiac surgery case. In spite of my extensive clinical experience
with NIRS, and in spite of this thesis, many questions about the
applicability of NIRS to optimize patient care remain.
Today, I am eager to explore two topics relating to NIRS. One
topic has arisen from the research for my thesis, the other one
remained in the background in favour of my thesis project. Now that
my thesis has finished, I am glad that time will come available to
explore these two topics in depth.
First, I would like to investigate more in detail the usefulness of
NIRS to monitor spinal cord perfusion. There is a clear need for
improved spinal cord monitoring during thoracoabdominal aortic
surgery. Currently, evoked potential monitoring is primarily used
to monitor spinal cord perfusion. However, due to its technical
complexity and constraints on anesthetic management, it is not widely
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used during thoracoabdominal aortic surgery. Our preliminary data
with NIRS (presented in chapter 4.4) were very promising, however
further investigations are required before a final conclusion can be
drawn. My aim is to compare NIRS with evoked potential monitoring,
and to evaluate whether measuring and intervening on the values
obtained by NIRS makes a difference in the neurologic outcome
of patients who underwent repair of extensive thoracoabdominal
aneurysms.
Second, as endothelial dysfunction is the earliest detectable stage
of atherogenesis, non-invasive endothelial function testing for the
purpose of cardiovascular risk stratification is very appealing. One
aspect of endothelial physiology is vasomotor function. The ability
of the endothelium to vasodilate in response to pharmacological and
physiological stimuli has been the most widely used clinical end point
for assessment of endothelial function [1].
Near-infrared Spectroscopy (NIRS) has been introduced as a way
to assess non-invasively microvascular reactivity in several disease
states [2]. It enables to quantify endothelium-mediated changes in
vascular tone, elicited by creating postocclusive reactive hyperemia
(PORH). PORH is a reproducible transient increase in blood flow
after release of an arterial occlusion. When the cuff is released, the
surge of blood flow causes an endothelium-dependent Flow Mediated
Dilatation (FMD) (Fig. 8.1). The speed of flow and the recovery
are mostly determined by the capacity of the microvasculature to
recruit arterioles and capillaries, reflecting the integrity of the mi-
crocirculation. NIRS proved to provide excellent reproducibility [3],
and demonstrated a coherent directional change with simultaneously
performed strain gauge plethysmography and radionuclide plethys-
mography [4]. Parameters of PORH measured by NIRS were able to
distinguish between healthy volunteers and patients with vascular
disorder [5].
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Figure 8.1: Parameters of postocclusive reactive hyperemia evaluated from
NIRS and TcpO2 signals. HbO2: oxyhemoglobin, TcpO2: transcutaneous
oxygen partial pressure, VO2: oxygen consumption, tR: time of recovery,
tM: time to peak value, ∆Chip: maximal change of the NIRS signal, HR:
maximal hyperemic response, tH: half time of the response. Ann Biomed
Eng 2001; 29: 311-20
We hypothesize that by means of NIRS we could introduce an
easy-to-use, user-independent method to estimate the cardiovascular
risk profile of patients and, consequently, that we might predict which
patients have a higher risk for compromized perfusion during the
critical perioperative period.
The purpose of future studies is to determine the applicability of
NIRS for quantification of PORH. In order to fulfill this task we aim
to: (1) determine the parameters of PORH measured by NIRS and
examine the reproducibility; (2) compare these results with the digital
pulse amplitude responses measured with the EndoPAT 2000 device
(Itamar Medical, Caesarea, Israel), which is widely recognized as the
standard method for non-invasive endothelial function assessment.
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Summary
The primary goal in the hemodynamic management of patients
undergoing surgery is to preserve oxygen delivery at a level sufficient
to cover all metabolic needs. Although it has been increasingly
demonstrated that clinical outcome is determined by optimizing tissue
oxygenation, specific target organ oxygen saturation still remains
poorly monitored in clinical anesthesia.
Within the last decades, near-infrared spectroscopy (NIRS)
is introduced with the potential to continuously assess tissue
oxygenation. NIRS is a noninvasive device that measures the
absorption of near-infrared light by tissue chromophores, a technique
similar to pulse oximetry. Specific wavelengths of near-infrared light
are emitted through the tissues lying below a sensor. Depending on
the amount of light reflected back to light detectors built into the
same sensor, regional oxygen saturation of the underlying tissue can
be determined.
In the present work, NIRS was used to detect perioperative
compromised perfusion, in order to explore the physiological
determinants of cerebral and peripheral tissue oxygen saturation in
different patient populations. The ultimate goal is the optimization
of patient management in daily anesthesia practice.
The brain, arguably our most important of organs and despite
being an obvious site of anesthetic action, ironically is inconsistently
the focus of targeted monitoring during anesthesia. Moreover,
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several clinical conditions routinely encountered in our daily medical
practice have the potential to disrupt the brain oxygen balance
exposing patients to the risk of intraoperative cerebral ischemia. In
this thesis, we demonstrated that monitoring of cerebral oxygen
saturation with NIRS allowed to identify global and regional cerebral
hypoperfusion, enabling real-time assessment of the effects of critical
events and therapeutic actions. Changes in cerebral oxygenation
were demonstrated to be related to blood pressure and pulsatility,
and to changes in CO2. We also indicated that the use of vasodilating
drugs might impair cerebral autoregulation.
The use of NIRS for monitoring regional oxygen saturation at
somatic sites has been advocated as an early warning system for
regional hypoperfusion. However, it remains to be identified which
changes in oxygen status of non-vital organs have to be intervened
upon. The present work demonstrated that NIRS provided real-time
assessment of renal, muscle, and spinal oxygen saturation during
aortic cross-clamping. Changes in tissue oxygen saturation were
pressure dependent, and seemed to be negatively affected by the
concomitant use of sodium nitroprusside.
The data in the present thesis demonstrate that tissue oxygen
saturation measured with NIRS provides a prompt responsive
monitor of changes in perfusion. However, in vivo changes in pressure
are accompanied by changes in flow, and therefore it remained
undetermined if maintaining pressure and/or flow was the best
strategy for prevention of perfusion deficit. We therefore explored
the impact of flow and pressure on cerebral and whole body oxygen
saturation during cardiopulmonary bypass, where flow and pressure
can be modified independently and in a controlled manner. In
this elective study population, maintaining flow seemed to be more
important than maintaining pressure. It is important to note that,
throughout all our studies, the lowest mean blood pressure values
were consistently higher than the reported critical value of 50 mmHg,
and therefore, the obtained results do not exclude perfusion pressure
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as an important variable. Nevertheless, our results are in accordance
with data demonstrating that organ injury can be prevented by
targeting oxygen delivery levels above a critical threshold.
Conclusion. In this thesis, NIRS has demonstrated its utility for
assessing specific target organ perfusion. The information provided
by this technology could significantly alter our management of
physiologic perturbations during anesthesia. Due to the advantage
of simple, continuous and non-invasive monitoring, NIRS has the
potential to become a valuable tool to optimize patient care in our
daily anesthesia practice.
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Samenvatting
Het doel van het hemodynamisch beleid tijdens anesthesie is om
de weefsels van voldoende zuurstof te voorzien. Het is bewezen
dat de klinische uitkomst beter is wanneer de weefseloxygenatie
geoptimaliseerd wordt, maar omwille van een aantal praktische
problemen, wordt de zuurstofverzadiging van specifieke organen tot
op heden niet routinematig gemonitord tijdens anesthesie.
Nabije-infrarood spectroscopie (NIRS) is een niet-invasieve
techniek die de mogelijkheid biedt om continu de weefseloxygenatie
te meten. Specifieke golflengtes van nabije-infrarood licht worden
door weefsel gezonden. Afhankelijk van de mate waarin de straling
geabsorbeerd wordt, kan de zuurstofsaturatie in het weefsel bepaald
worden.
De doelstelling van deze thesis was om door middel van NIRS
oxygenatieproblemen ter hoogte van de hersenen en de perifere
weefsels te detecteren, en de fysiologische determinanten van de
weefselsaturatie te bepalen. Het uiteindelijk doel is de optimalisatie
van het hemodynamisch beleid in de dagelijkse anesthesie praktijk.
Meerdere factoren tijdens anesthesie kunnen de zuurstofbalans in
de hersenen verstoren, met mogelijks cerebrale letsels tot gevolg.
Desondanks worden de hersenen momenteel niet routinematig
gemonitord. In deze thesis toonden we aan dat NIRS monitoring
zowel globale als regionale cerebrale hypoperfusie kan detecteren.
Veranderingen in cerebrale oxygenatie waren gerelateerd aan bloed-
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druk en pulsatiliteit, en aan CO2 veranderingen. We toonden ook
aan dat bloedvatverwijdende medicatie de cerebrale autoregulatie
kan verstoren.
Tijdens operaties waarbij een aortaklem geplaatst werd, toon-
den we aan dat NIRS onmiddellijk veranderingen in de nier-,
spier-, en ruggenmergsaturatie detecteerde. De veranderingen in de
weefselsaturaties waren drukafhankelijk, en werden negatief be¨ınvloed
door het gebruik van sodium nitroprusside.
De gegevens in dit proefschrift toonden aan dat de met
NIRS gemeten weefseloxygenatie een snelle weergave geeft van
doorbloedingsveranderingen. Echter in vivo gaan bloeddrukveran-
deringen steeds gepaard met flowveranderingen, en daarom blijft de
vraag of druk dan wel flow de beste strategie is om perfusietekort
te voorkomen. Daarom onderzochten we het effect van druk en
flow op de cerebrale en globale zuurstofsaturatie tijdens cardiopul-
monale bypass, waarbij flow en druk gecontroleerd en onafhankelijk
van elkaar kunnen veranderd worden. Uit deze studie bleek dat
flow belangrijker is dan druk voor het behoud van cerebrale en sys-
teem oxygenatie. Het is evenwel belangrijk op te merken dat, in al
onze studies, de laagste gemiddelde bloeddrukwaarden steeds hoger
waren dan de algemeen aanvaarde kritische waarde van 50 mmHg,
en dat derhalve de verkregen resultaten perfusiedruk niet uitsluiten
als een belangrijke variabele. Desalniettemin zijn onze resultaten
in overeenstemming met gegevens die aantonen dat orgaanschade
kan voorkomen worden door de zuurstofaanvoer boven een bepaalde
kritische drempel te houden.
Besluit. In dit proefschrift toonden we aan dat NIRS snel en
betrouwbaar weefseloxygenatieproblemen detecteerde. Door een
beter begrip van de fysiologische veranderingen tijdens anesthesie
kan deze techniek het anesthetisch beleid optimaliseren.
List of abbreviations
AUC area under the curve
BIS bispectral index
CBF cerebral blood flow
CEA carotid endarterectomy
CO2 carbon dioxide
CPB cardiopulmonary bypass
CPP cerebral perfusion pressure
CVP central venous pressure
CX aortic cross-clamping
DO2 systemic oxygen delivery
EtCO2 end-tidal concentration of carbon dioxide
ETsevo end-tidal concentration of sevoflurane
FiO2 fractional inspired oxygen
Hb hemoglobin
HHb deoxygenated hemoglobin
Hct hematocrit
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HR heart rate
ICP intracranial pressure
LLA lower limit of autoregulation
MAP mean arterial blood pressure
MMD moyamoya disease
NTG nitroglycerin
OER oxygen extraction ratio
O2Hb oxygenated hemoglobin
OPCAB off-pump coronary artery bypass
PaCO2 arterial carbon dioxide partial pressure
PaO2 arterial oxygen partial pressure
PtO2 tissue oxygen tension
PvCO2 venous carbon dioxide partial pressure
PvO2 venous oxygen partial pressure
Q pump flow
rScO2 regional cerebral oxygen saturation
SaO2 arterial oxygen saturation
SAP systolic arterial blood pressure
ScO2 cerebral oxygen saturation
Sevo sevoflurane
SjvO2 jugular vein oxygen saturation
SmO2 muscle oxygen saturation
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SmvO2 mixed venous oxygen saturation
SNP sodium nitroprusside
SpO2 pulse oximetry
SsO2 spinal oxygen saturation
SR Spatial Resolution
SrO2 renal oxygen saturation
SRS Spatially Resolved Spectroscopy
SvO2 venous oxygen saturation
TAAA thoracoabdominal aortic aneurysm
THb total hemoglobin
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